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                                            ABSTRACT 
 
Garcinia kola is one of the plants used in folklore remedies for the treatment of microbial 
infections. Bacterial resistance to commonly used antibiotics has necessitated the search for 
newer and alternative compounds for the treatment of drug resistant microbial infections. 
This study focuses on the bioactivity of G. kola seeds on Streptococcus pyogenes (ATCC 
49399), Staphylococcus aureus (NCTC 6571), Plesiomonas Shigelloides (ATCC 51903) and 
Salmonella typhimurium (ATCC 13311), organisms which can cause illnesses from mild to 
severe with potentially fatal outcomes. The crude ethyl acetate, ethanol, methanol, acetone 
and aqueous extracts were screened by agar-well diffusion method and the activities of the 
extract were further determined by Minimum Inhibitory Concentration (MIC) and Minimum 
Bactericidal Concentration (MBC) assays. The inhibition zones ranged from 0 - 24 mm, 
while MIC and MBC of the extract ranged between 0.04 - 1.25 mg/mL and 0.081 - 2.5 
mg/mL respectively.  Chloroform/ Ethyl Acetate/ Formic acid (CEF) solvent system 
separated more active compounds followed by Ethyl Acetate/ Methanol/ Water (EMW) and 
Benzene/ Ethanol/ Ammonium Hydroxide (BEA). The extracts were fractionated by Thin 
Layer Chromatography (TLC). Bioautography was used to assess the activity of the possible 
classes of compounds present in the more active extracts. Column chromatography was used 
to purify the active compounds from the mixture while Gas Chromatography-Mass 
Spectrometry (GC-MS) was used to identify the phyto components of the fractions. The MIC 
of the fractions ranged between 0.0006 - 2.5 mg/mL.  CEF 3 (F3), CEF 11 (F11) and CEF 12 
(F12) revealed the presence of high levels fatty acids Linoleic acid, 1, 2-Benzenedicarboxylic 
acid and 2, 3-Dihydro-3, 5-dihydroxy-6-methyl, respectively. The results obtained from this 
study justify the use of this plant in traditional medicine and provide leads which could be 
further exploited for the development of new and potent antimicrobials. 
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                               CHAPTER ONE 
1.1 Introduction 
Streptococcus pyogenes is a Gram-positive, non-spore forming, facultative anaerobic 
bacterium that occurs as long chains of cocci and occasionally in pairs. The metabolism of S. 
pyogenes is fermentative; it is catalase negative. It requires an enriched medium containing 
blood for growth. It is the cause of many diseases ranging from mild superficial skin 
infections to life threatening diseases. Infections typically begin in the throat and include 
pharyngitis (strep throat) and localized skin infection. Severe infections include necrotizing 
fasciitis and streptococcal toxic shock syndrome; and it is the most common bacterial cause 
of sore throat (Todar et al., 2005). It evades the immune response and spread by penetrating 
host tissue layers. S. pyogenes releases a number of toxins into its host. The treatment of 
choice is penicillin for a minimum of 10 days. Macrolides, chloramphenicol and tetracyclines 
are used if the strain isolated has been shown to be sensitive, but resistance is much more 
common. An increased macrolide resistance rates in the clinical isolates of S. pyogenes have 
been reported in many parts of the world (Palavecino et al., 2001). A decrease in 
susceptibility of S. pyogenes to erythromycin and tetracycline has also been reported (Jasir et 
al., 2000). The application of topical antibiotics such as mupirocin or ointment (Bactroban) 
and fusidic acid are also used and high resistance rates have been reported with the use of 
fusidic acid, ranging from 32.5 -50% (Oranje et al., 2007). 
Staphylococcus aureus is a facultative anaerobic, non-motile, non-spore forming, catalase 
positive and Gram-positive coccus which appears as grape-like clusters when viewed under 
the microscope. These potentially pathogenic bacteria are found in nasal or mucous 
membranes, hair follicles and peritoneum of warm blooded animals. They are able to invade 
via the broken skin or mucous membranes; hence intact skin is an excellent human defence. 
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People with weak immune systems and  open wounds or who just had surgery are most at 
risk for developing S. aureus infection; it is spread primarily by food handlers with 
Staphylococcus infections on the skin (Tolan, 2000). S. aureus can cause food poisoning, 
toxic shock syndrome and pneumonia. Toxic shock syndrome is characterized by sudden 
onset of high fever, vomiting, diarrhea and muscle aches followed by hypotension which can 
lead to death. Penicillins with beta-lactamase-inhibitor such as amoxicillin plus clavulanic 
acid are used to treat S. aureus infections. Patients allergic to penicillin are treated with 
vancomycin, although for minor infections macrolides such as erythromycin may be 
adequate. Penicillin resistance in S. aureus is due to production of the enzyme beta-lactamase 
(penicillinase) (Klytmanns et al, 1997). The occurrence of vancomycin resistant S. aureus has 
been reported (Kasloom et al., 2006). S. aureus has been a stumbling block for antimicrobial 
chemotherapy and introduction of new classes of antimicrobial agents is usually followed by 
the emergence of resistant forms of pathogens (Aborzi et al., 2000). 
Plesiomonas shigelloides is a Gram-negative, facultative anaerobic, oxidase positive, 
flagellated rod belonging to the family Enterobacteriaceae (Garrity et al., 2004). It is an 
aquatic microorganism, recognized as a potential human and animal pathogen. P. shigelloides 
is extensively distributed in the environment (Salerno et al., 2007). It is commonly found in 
fresh and brackish water, freshwater fish, shellfish and different types of animals such as 
cattle, goats, swine, cats, dogs, monkeys, vultures, snakes and toads. Human infections due to 
this bacterium are mostly waterborne and cause gastroenteritis with fever, chills, abdominal 
pain, nausea, diarrhea and vomiting (Ueda et al., 1999). Extra intestinal complications such 
as septicemia and death may occur in immunocompromised people. The usual route of 
transmission is by ingestion of contaminated water or raw shellfish. Most  P. shigelloides 
strains are resistant to broad spectrum penicillins such as ampicillin, piperacillin, 
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carbenicillin, azlocillin and others (Avison et al., 2001). Susceptibility of the organism to 
carbapenems and cephalosporins has been demonstrated (Obi et al., 2007). 
Salmonella typhimurium is a Gram - negative, non-spore forming, and catalase positive, 
oxidase negative and facultative anaerobic bacterium. It is a significant cause of morbidity 
and mortality in humans and animals with multidrug resistance being an emerging problem 
(Hendrieksen et al., 2004). Contaminated food of natural origin, particularly meat products 
from cattle and pigs, is an important source of S. typhimurium in human infections (Evans et 
al., 1996). Although it does not cause clinical disease in pigs, subclinical infection constitutes 
an important food-safety problem throughout the world (Kranker et al., 2003). It causes 
gastroenteritis in humans and other mammals. It is one of the main serovars of Salmonella 
enterica causing illness like typhoid-like disease in mice. The disease caused by this 
bacterium in humans is characterized by diarrhea, abdominal cramps, vomiting and nausea 
and generally last up to seven days. Fluoroquinolones are used for treatment in adults; 
cephalosporins given by injection are widely used in children, as quinolones are not generally 
recommended for this group. Other drugs such as chloramphenicol, ampicillin, amoxicillin 
and trimethoprim-sulfamethoxazole are occasionally used as alternatives. The emergence of 
multidrug-resistant serotypes, especially S. typhimurium definitive phage-type (DT) 104, has 
become a potential problem of animal husbandry and in human medicine (Butaye et al., 
2006) and therefore effective antimicrobials are essential for treatment. 
Garcinia kola is a medium sized evergreen tree which grows about 15-17m high (Plowden, 
1972). It is cultivated and distributed throughout the West and Central Africa and found 
mostly in moist conditions. It produces a characteristic smooth elliptically shaped seeds, with 
yellow pulp and brown seed coat. It is also referred to as “bitter kola” because of the 
astringent taste. The seeds are culturally and socially significant in some parts of West Africa 
and are served for traditional hospitality in private, social and cultural functions. The seeds 
4 
 
have been found to have broad spectrum antibacterial activity (Akinpelu et al., 2008). This 
has been demonstrated with Bacillus subtilis (NCIB 3610), Streptococcus faecalis (NCIB 
775), Staphylococcus aureus (NCIB 8588), Klebsiella pneumoiae (NCIB 418), H.pylori 
(Akinpelu at al., 2008; Njume et al., 2011) and other organisms with methanolic extract of 
the seeds. The phytochemical compounds isolated from G. kola seeds includes biflavonoids 
such as kolaflavone and 2-hydroxybi-flavonoids (Okunji et al., 2002), biflavonones (GB -1, 
GB-2) (Cotterin et al., 2000). Other compounds include triterpenes, xanthones and (1-3, 8-
11) benzophenones (Okunji et al., 2007). Although studies have been done with this plant, 
the seeds in most cases were obtained from Nigeria and majority of the studies have 
concentrated on several organisms excluding some of the organisms used in this study. Most 
studies have been done with aqueous, petroleum, butanol and diethyl ether extracts of the 
seeds which might limit the antimicrobial potentials of plants. The type of solvent used may 
have an effect on the nature of compounds extracted and the resulting bioactivity of the 
extract (Eloff et al., 2008). These observations of antibacterial activity of G. kola suggest that 
it could be a potential source of therapeutically useful compounds for the treatment of various 
infections and therefore further investigation of the plant are required. 
1.2 Statement of the problem 
The problem of antibacterial resistance, to commonly used antibiotics has led to a search for 
newer and alternative compounds for the treatment of drug-resistant infections (Sibanda et 
al., 2008). Several findings on chemotherapeutic potentials of plants have shown that they 
can be sources of antimicrobial compounds of value and a typical example of such plant is 
Garcinia kola (Rabe et al., 1997; Njume et al., 2011). Presently there are global problems of 
antibiotic resistance to infections coupled with the emergence of new and re-emerging 
diseases. There is also a belief that the use of plants for medicinal purposes has been 
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associated with less side effects (Tolan, 2000). There is therefore a need to search for more 
efficacious and cost-effective antimicrobial agents of natural origin to complement the 
existing synthetic antimicrobial drugs that are becoming less potent against pathogenic 
microorganisms (Ncube et al., 2008). 
1.3 Hypothesis 
G. kola has potent antimicrobial activity against S. pyogenes, S. aureus, P. shigelloides and S. 
typhimurium. 
1.4 Overall objective 
The overall objective was to ascertain the bioactivity of Garcinia kola seeds on selected 
bacterial pathogens. 
1.5 Specific objectives 
The specific objectives of this study were to: 
1. Screen the plant extracts (ethyl acetate, ethanol, methanol, acetone and aqueous) for    
    antimicrobial activity. 
2. Determine the Minimum Inhibitory Concentration (MIC).  
3. Determine the Minimum Bactericidal Concentration (MBC). 
4. Purify and characterize the active compounds by Column chromatography and Gas- 
    Chromatography Mass - Spectrometry (GC-MS).                                                                                                         
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                                            CHAPTER TWO 
                                               Literature Review 
 
2.1 Streptococcus pyogenes  
2.1.1 Brief history   
S. pyogenes was first discovered by Billroth in 1874 in patients with wound infections. In 
1883, Fehleisen isolated the chain forming bacteria in pure culture from perierysipelas 
lesions. The organism was named S. pyogenes in 1884 by Rosebach. This name is derived 
from the word pyogenic which is a classification for the streptococci that are associated with 
the formation of pus. In 1930’s advances in hemolytic and non-hemolytic were made by 
Lancefield.  S. pyogenes  display an antigen A on its cell wall and because of this it has been 
classified by Lancefield serotyping as group A. Various studies made by Mueller and Brown 
in 1903 and 1919 respectively led to knowledge of different patterns of hemolysis as alpha, 
beta and gamma hemolysis. A later development in this field was the Lancefield 
classification of beta-hemolytic streptococci by serotyping based on M-protein precipitation 
reactions. Hippocrates was an ancient physician who studied and recorded observances on the 
infections and physiology of the body and described the relative symptoms of the flesh-eating 
bacteria in the early stages. The critical role of M-protein in causing diseases was established 
by Lancefield. In the early 1900s, Doches, George and Dick identified haemolytic 
streptococcal infection as the cause of scarlet fever. The epidemiological studies made in the 
1900s helped established the link between Group A Streptococcus infection and acute 
rheumatic fever and acute glomerulonephritis (Khan et al., 2009). 
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2.1.2 Morphology 
S. pyogenes is a Gram-positive bacterium that grows as long chains or in pairs (Ryan, 2004). 
Individual cells are round to ovoid cocci, about 0.6 - 1.0 micrometer in diameter. The cell 
wall of S. pyogenes is very complex and chemically diverse. The organism has a rigid cell 
wall, inner plasma membrane with mesosomal vesicles, cytoplasmic ribosomes and a 
nucleoid (Joklik et al., 2000). It also consists of filamentous pili to adhere mechanically 
(Manetti et al., 2007). 
2.1.3 Pathogenesis and clinical manifestation 
S. pyogenes has several virulence factors that enable it to attach to host tissues, evade the 
immune response, and spread by penetrating host tissue layers. As a rule, individual species 
of S. pyogenes are classified based on their hemolytic properties (Patterson, 1996). It is 
commonly known as beta-hemolytic group A Streptococcus or GAS (Todar et al., 2002). 
Hemolysis is the breakdown of red blood cells. Alpha hemolysis is caused by an oxidation of 
iron in haemoglobin which gives a greenish colour on blood agar. Beta-hemolysis is complete 
rupture of red blood cells which gives distinct, wide, clear areas around bacterial colonies on 
blood agar (Facklam, 2002).  
The antigenic components of the cell are the virulence factors. The cell surface accounts for 
many of the bacterium’s determinants of virulence. This includes capsular polysaccharides, 
peptidoglycan, lipoteichoic acids and certain membrane proteins in addition to several 
structural proteins. These allow bacteria to adhere to surfaces, spread throughout the body, 
hemolyze blood cells and necrotize tissue. The capsule makes it possible for the organism to 
become resistant to phagocytosis. M-proteins show clearly virulence factors associated with 
both colonization and resistance to phagocytosis (Falagas, 2008). M-protein is a 
macromolecule incorporated in fimbriae present on the cell membrane which protects the 
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bacterial cell wall.  The ability of S. pyogenes to cause disease greatly depends upon these 
proteins. The fibronectin collagen-T-antigen (FCT) is a region that allows the adherence of 
the S. pyogenes to epithelial cells (Baldassarri et al., 2006). They have been identified based 
on the antigenic specificity and are the major cause of antigenic shift and drift among the 
Group A Streptococcus pyogenes.  This organism produces a large number of extracellular 
proteins that cause an increase in its virulence ability which triggers a serious non-specific 
immunological response in the human host.  The extracellular components responsible for 
diseases include invasins and exotoxins. Another unique property that distinguishes this 
bacterium from the others is a protein called a fibronectin binding protein that allows it to 
adhere to respiratory epithelial cells (Hunski et al., 1992).  The pili found in GAS which are 
normally found in gram-negative bacteria have important virulence factors that are used for 
adhesion on target cells. Reports on these pili have shown that they are made up of proteins 
from the same family, suggesting that they are also found in gram-positive bacteria. They 
were also investigated further and discovered to have effective antigens that protect against 
lethal infections (Mora et al., 2005).  This virulence factor enables the organism to attach and 
stick to host cell tightly and not let go.   
Colonization of the upper respiratory tract and acute pharyngitis may result in spreading to 
other portions of the upper or lower respiratory tracts which causes infection of the ear, 
sinuses and lungs (pneumonia). During these aspects of acute diseases, the organism brings 
into play a variety of secretory proteins that mediate invasion (Clark, 2009). S. pyogenes 
produces a wide range of skin and soft tissue infections and the severity of the illness 
associated with these infections is extremely variable (Baddour, 1993). The infections 
typically begin in the throat or skin. In human, it is the cause of many diseases ranging from 
mild superficial skin infections which include pharyngitis (Strep throat) and localized skin 
infection such as impetigo, erysipelas and localized cellulitis characterized by fever and 
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tenderness (Stevens et al., 1996; Pierre et al., 2003; Smeesters et al., 2010). Other infections 
include acute rheumatic fever, rheumatic heart disease and acute glomerulonephritis (Malin et 
al., 2006). If strep throat is not treated it can develop into rheumatic fever which is a disease 
that affects the joints and heart valves. Other toxigenic infections may lead to Streptococcal 
toxic shock syndrome which can be life threatening (Ryan et al., 2004). It can also cause soft 
tissue infections such as pyoderma myositis, osteomyelitis, pneumonia as well as severe 
systemic disease and long term non-suppurative complications (Zartash et al., 2009). 
2.1.4 Laboratory diagnosis 
Being responsible for a variety of diseases, various methods are available to diagnose the 
bacteria. Group A Streptococcus (GAS) infection is generally diagnosed with a Rapid Strep 
Test (RST) or by culture. This RST or Rapid Antigen Detection (RADT) is done to determine 
if a patient has Streptococcal pharyngitis, which is a group A Streptococcal infection of the 
pharynx and possibly other parts of the body (Robers et al., 2002). The bacterial swab is then 
subjected to either enzyme or acid techniques to extract bacterial antigens (Koo, 2009). Strep 
throat is commonly diagnosed through a throat culture by taking a throat swab. Once the 
throat has been swabbed, the cells are smeared onto blood agar that allows the bacteria to 
grow, with added bacitracin antibiotic disk to show beta-haemolytic colonies and sensitivity 
(zones of inhibition around the disk). Results are typically available within 24 to 48 hours. 
Serological identification of the organism involves testing for the presence of group A by 
Phadebact test (Ulug et al., 2009). The gold standard method used to characterize S. pyogenes 
is emm typing based on sequence analysis of variable distal portion of the gene that encodes 
the M-protein which is the virulence factor (Le Hello et al., 2010). 
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2.1.5 Epidemiology 
It is estimated that between 5-15 % of normal individuals harbour S. pyogenes usually in the 
respiratory tract without signs of disease. It has been reported that invasive GAS infections 
carry a mortality rate of 5-15 % with Streptococcal Toxic Shock Syndrome (STSS) and 
necrotizing fasciitis with fatality rates over 35% and approximately 25% respectively (CDC, 
2008). About 9,000-11.5000 cases of GAS disease occur each year in the United States, 
resulting in 1.000-1.800 deaths, with STSS and necrotizing fasciitis each accounting for 6-7% 
of these invasive cases. There are several million cases of Strep throat and impetigo every 
year. Streptococci are also part of the normal commensal flora of the mouth, skin, intestine 
and upper respiratory tract of humans. Studies have reported that S. pyogenes also exists in 
the vagina (Larsen et al., 2001). Initially, it was not considered as a cause of bacterial 
vaginosis (Donald et al., 1991; Stricker et al., 2003). A report on incidence of vaginosis 
showed an increased rate in the past two decades (Efstratiou et al., 2001; Sweet et al., 2001; 
Peterson et al., 2006). 
 Invasive GAS infections occur when the bacteria get pass the defences of the person who is 
infected. This may occur when a person has sores or other breaks in the skin that allow the 
bacteria to get into tissues. Respiratory droplet spread is the major route of transmission 
associated with upper respiratory tract infection. Children with untreated acute infections 
spread organisms by airborne salivary droplets and nasal discharge (Schleiss, 2010). Studies 
regarding S. pyogenes vaginosis suggest that the organism is introduced to the genital area by 
people that carry the bacterium in their respiratory tract either as normal flora or pharyngeal 
infection (Stricker et al., 2003). 
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2.1.6 Treatment 
Streptococcal infections can be treated with many antibiotics. Diseases caused by S. pyogenes 
typically respond to antibiotics such as penicillin which is the most commonly prescribed 
medication to treat these diseases for about 10 days (Falagas et al., 2008). High doses of 
penicillin and clindamycin are recommended for treatment of STSS and necrotizing fasciitis. 
Studies have reported increasing MIC or less susceptibility to penicillin (Amabile-Cuevas et 
al., 2001). Failure of treatment with penicillin is due to other local commensal organisms 
producing β-lactamase, or failure to achieve adequate tissue levels in the pharynx. The genes 
encoding beta-lactamases are found to be located on either bacterial plasmids or 
chromosomes (Aarts et al., 2006). However, individuals with severe illnesses may need 
supportive and intensive care. Necrotizing fasciitis often involves the surgical removal of all 
infected tissue, since the bacteria spreads rather quickly. Macrolides, chloramphenicol and 
tetracyclines are also used if the strain isolated has been shown to be sensitive (Watthaiou et 
al., 2008). Tetracycline resistance have been reported as a result of new genes uptake 
(Chopra et al., 2001). Frequent S. pyogenes resistance to macrolides antibiotics have been 
reported in some countries (Richter et al., 2008). About 5-50 % of macrolide resistance has 
been shown to increase worldwide (Shuckcloth et al., 2004; Erdem et al., 2005; Shibl et al., 
2005). Macrolides resistance is usually developed by efflux (encoded by mef A) or target 
modification due to ribosomal methylation (encoded by erm B or erm A) (Leclercq, 2002).  
Resistance to fluoroquinolones by this organism has also been reported (Yan et al., 2008). 
They have been reported to be potent inhibitors of bacterial DNA replication and point 
mutations and reduced intracellular accumulation are the two mechanisms of resistance to 
fluoroquinolones. The growing number of macrolide resistant strains of S. pyogenes is an 
increasing worldwide problem. This resistance has been shown to differ among countries in 
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different geographic areas (Palevecino et al., 2001; Bergman et al., 2004; Rubinstein et al., 
2005). The ability of the organism to produce biofilm has been reported to be one of the other 
reasons for antibiotic failure. This was tested by isolating S. pyogenes strains and analysing 
their ability to form biofilms and results indicated that most of the strains (90%) isolated 
produced biofilm. The data showed that these biofilm forming isolates entered epithelial cells 
with significantly lower efficiency that those which are not able to produce biofilm 
(Baldassarri et al., 2006). This simply means that if particular strains are unable to enter 
epithelial cells in order to escape the antibiotic they will instead result in the formation of 
biofilms as an alternative way of surviving in the host. 
2.1.7 Prevention and control 
The spread of S. pyogenes can be reduced by good hand washing, especially after coughing 
and sneezing and before preparing food. Earlier studies have reported protective immunity 
against mucosal S. pyogenes challenge by intranasal administration of the M-protein C repeat 
region expressed on vaccinia virus, which led to the reduction in nasopharyngeal colonization 
(Rabinowits et al., 2009). One strategy to develop a broad strain coverage S. pyogenes 
vaccine is the design of vaccines based on the conserved C repeat region of the M protein 
(Fischetti et al., 1989). Although current measures for treatment and prophylaxis for 
Streptococcal diseases rely on chemotherapy, there is a consensus that in the longer term, 
vaccination might constitute the most effective strategy to diminish the global burden caused 
by this pathogen. The development of an efficient anti-S. pyogenes vaccine is widely 
regarded as the major priority and there is consensus that vaccination might constitute the 
most effective strategy to slow down global disease caused by this organism (Siegert et al., 
2006). 
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2.2 Staphylococcus aureus 
2.2.1 Brief history  
This organism was discovered in Arberdeen, Scotland in 1880 by a surgeon, Sir Alexander 
Ogston in pus collected from surgical abscesses (Ogston, 1984). Alexender Ogston and Louis 
Pasteur had reproduced human pyemic infections in mice and rabbits by inoculating pus-
derived cultures (Parker et al., 1931). Staphylococcal infections were found in 5,000000 
patients in American hospitals every year (Ogston, 1984). 
2.2.2 Morphology 
S. aureus is a gram-positive coccus, which appears as grape-like clusters when observed 
under the microscope. It has large, round, smooth, slightly raised, golden to yellow colonies 
often with hemolysis when grown on agar plates (Ryan et al., 2004; Jumidge et al., 2008). 
The carotenoid pigment Staphyloxanthin is responsible for S. aureus characteristic golden 
colour. The Staphylococci are perfectly spherical cells about 1 micrometer in diameter. These 
organisms grow in clusters because the cells divide successively in three perpendicular planes 
with the sister cells remaining attached to one another following each successive division 
(Todar, 2008). The cell wall contains peptidoglycan and teichoic acid. 
2.2.3 Pathogenesis and clinical manifestation 
The portal of entry for S. aureus may be a hair follicle, but usually is a break in the skin 
which may be a minute needle stick or a surgical wound. Methicillin-resistant S. aureus 
colonizes the skin particularly in the rectum and perineal area (Lee et al., 2011).  Report have 
also showed that  this strain also colonize the pharynx, gut and vagina (Nowrouzian et al., 
2011; Milstone et al., 2010; Nakamura et al., 2010). During colonization of this organism to 
host tissues virulence genes are believed to be triggered (Novick, 2003). This organism may 
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cause diseases through tissue invasion and toxin production (Barlett et al., 2010). S. aureus 
show many potential virulence factors such as surface proteins that promote colonization of 
the host tissues. Invasins such as leukocidin, kinases and hyaluronidase promote the 
spreading of bacteria in tissues. Surface factors such as the capsule and protein A inhibits 
phagocytic engulfment (Todar, 2004). A number of complement inhibitors prevent opsonins 
from binding the bacterium and therefore avoid destruction (Foster et al., 2005; Rooijakkers 
et al., 2005). The variety of molecules that S. aureus uses in adhering and invading the host 
epithelial cells are collectively called Microbial Surface Components Recognizing Adhesive 
Matrix Molecules (MSCRAMM) (Weidenmaier et al., 2004). These molecules as well as the 
bacterial products play a role in adhesion and attachment to nasal epithelial cells. Two factors 
(clumping factor B and wall associated teichoic acid) have proven roles in nasal colonization 
of humans (Wertheim et al., 2008). Nasal carriage is the most important because nose-
picking could effectively disseminate the bacterium to other body surfaces (Verbrugh et al., 
2006).   
The organism can cause a variety of pus-forming infections and toxinoses in humans. Strains 
producing enterotoxin cause foodborne diseases. The patient present acute onset of vomiting 
and diarrhea after two to six hours of ingestion. It causes superficial skin lesions such as 
styes, boils, and furuncules; more serious infections such as pneumonia, phlebitis, meningitis, 
and urinary tract infections; and deep-seated infections, such as osteomyelitis and 
endocarditis. It is a major cause of hospital acquired (nosocomial) infection of surgical 
wounds and infections associated with indwelling medical devices (Todar, 2008). There have 
been reports on S. aureus causing mastitis in cattles and this result in economic loss (Younis 
et al., 2000). 
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2.2.4 Laboratory diagnosis 
An appropriate specimen is obtained accordingly depending on the type of infection and sent 
to the laboratory for identification by using biochemical or enzyme-based tests. A gram-
positive test is performed first to show typical gram-positive bacteria, cocci in clusters. After, 
the isolates are cultured on mannitol salt agar, which is a selective medium with 7-9% of 
Sodium Chloride (NaCl). Sodium Chloride allows S. aureus to grow, producing yellow-
coloured colonies as a result of mannitol fermentation and a drop in pH of the medium. The 
ability of the organism to clot plasma is also the other identification of this organism. 
Phenotypic methods in developing countries are important in diagnosis of infections; 
coagulase tests are used to confirm the presence of S. aureus. These kinds of test are done in 
the laboratory using a tube coagulase test (clumping factor) and tube slide coagulase methods 
(Koneman et al., 1997). A tube test detects free coagulase whereas slide test detect bond 
coagulase. The bond coagulase causes organims to aggregate by reacting with fibrinogen. 
Extracellular staphylocoagulase reacts with prothrombin in order to form staphylothrombin, 
which is capable of converting fibrinogen to fibrin. The performance of this test vary in the 
ability to produce results even though is effective; improvement on this method is required in 
order to give excellent results (Martineau et al., 1998; Bello et al., 2006).  
Studies have reported that approximately 97% of S. aureus organisms isolated from humans 
have both form of coagulase (Tolan et al., 2011). The tube test is more preferred due to its 
reliance on human plasma, other plasmas from rabbits and horses are recommended but if 
available they can be expensive or be of poor quality. The presence of the enzyme coagulase 
differentiates between the virulent and less virulent strain of S. aureus. Techniques such as 
real time and quantitative PCR are increasingly employed in clinical laboratories (Francois et 
al., 2008). The tools support infection control strategies to limit spread of the bacteria 
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(Schrenze et al., 2008). The clones of this organism have been found to be relatively stable 
and differentiate if there is no frequent interstrain recombination, this make it possible to 
discern different clones as well as clonal lineages by molecular typing (Feil et al., 2003). 
2.2.5 Epidemiology 
It has been estimated that about 30-50 % of the human population are Staphylococcus carriers 
(Bhatia et al., 2007). It is a frequent part of the skin flora found in the nose and on the skin. 
Children carry the organism more persistently than adults (Verkaik et al., 1999). More than 
80 % of health care-associated S. aureus infections are endogenous (Eliff et al., 2001; 
Wertheim et al., 2004). It has been found that among healthy adults, carrier rates of 11-32 % 
were detected in the general population and a prevalence of 25 % was detected in hospital 
personnel (Wencel et al., 1995). Remarkably, 20 % of individuals are persistently colonized 
in the nose and 30 % are transiently colonized. Colonization of S. aureus is also more 
frequent in patients with HIV and diabetes (Wertheim et al., 2005). 
 Mortality rate caused by Staphylococcal infections varies. Untreated bacteremia showed a 
mortality rate exceeding 80 % and that of Staphylococcal toxic shock syndrome 3.5% 
(Thomas, 2011). Mortality in patients suffering from S. aureus bacteremia associated with 
thrombocytopenia has been reported (Gafter-Gvili et al., 2011). Infections occur as a result of 
inoculation of the organism into an open wound; mucosal surfaces that harbour the organism 
include the nose, throat, vaginal wall and gastrointestinal tract (Wertheim et al., 2004). 
Infection can spread through contact with pus from an infected wound, skin to skin contact 
with an infected person by producing hyaluronidase that destroys the tissues. It can also 
spread through the air and contact with objects such as towels, sheets, clothing or athletic 
equipment used by an infected person. Individuals can carry the bacteria from one area of 
their body to another or pass it to other people through dirty hands and fingernails.  
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2.2.6 Treatment 
The treatment of choice for Staphylococcal infections is penicillin which can be resistant in 
some countries. First line therapy is most commonly a penicillinase-resistant beta-lactam 
antibiotic. Combination therapy with gentamicin may be used to treat serious infections such 
as endocarditis (Campion et al., 2009). Methicillin used to be the standard agent remaining 
for treatment but is no longer used very much due to the emergence and spread of methicillin-
resistant S. aureus (Nigro et al., 2005). This community acquired methicillin-resistant strain 
is virulent and is frequently occurring (Baba et al., 2002). Vancomycin is often a treatment of 
choice in infections with methicillin-resistant S. aureus but the occurrence of vancomycin 
resistant S. aureus has been found (Kalsoom et al., 2006). Mupirocin is applied for 
decolonization and prevention of invasive infections in patients taking long time dialysis 
treatment (Laupland et al., 2003).  In other non-surgical patients the application of mupirocin 
had no effect on the rate of health care-associated infections with this organism (Wertheim et 
al., 2004). Drainage of pus collection, surgical removal of dead tissues and removal of 
foreign bodies can be applied for treatment (Simms et al., 1992). This organism has a record 
of developing resistance quickly to antibiotics and this has been noticed as one of the 
paramount microbial threats (Smoliski et al., 2003). It has been recognized as having the 
ability to develop changes in their sensitivity to antimicrobials (Oliveira et al., 2006). 
2.2.7 Prevention and control 
Emphasis on basic hand washing techniques and the use of disposable aprons and gloves are 
effective in preventing transmission. Natural deterrents such as honey and garlic can help 
fight or prevent S. aureus infections (Buhner, 1999). It can also be prevented by covering any 
open skin such as abrasions and cuts with clean dry bandages as well as avoiding of sharing 
personal items such as towels and razors. Decolonization can also be prevented by washing 
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with disinfecting soap such as chlorhexidine gluconate products (Lonneke et al., 2010). 
Recent studies support the recommendation for careful cleaning of environmental surfaces 
and disinfection items (Muto, 2003). S. aureus has been a stumbling block for antimicrobial 
chemotherapy and the introduction of new classes of antimicrobial agents is usually followed 
by the emergence of resistant forms of pathogens (Alborzi et al., 2000).  
2.3 Plesiomonas shigelloides 
2.3.1 Brief History  
P. shigelliodes was first isolated from the faeces of a patient by Ferguson and Henderson in 
1947 and called this bacterium Paracolon C27, a motile organism which possessed sonnei 
phase I antigen. This microorganism has been renamed several times. In 1954, Bader 
suggested to include the bacterium within the genus Pseudomonas with the species name 
shigelloides (Bader, 1954). It was moved from the Pseudomonas genus and included within 
the genus Aeromonas with the species shigelloides within the family vibrionaceae, because 
of the flagella morphology and the cytochrome oxidase activity (Ewing et al., 1961). In an 
evaluation of the amplified fragment length polymorphism (AFLP) technique for genotyping 
Aeromonas species, Huys and Sings found out that P. shigelloides is phylogenetically related 
to the genus Proteus (Huys and Sings, 1999). The genus Plesiomonas has been moved to the 
family Enterobacteriaceae, in the light of these research finding (Garrity et al., 2001). 
2.3.2 Morphology 
P. shigelloides is gram-negative, capsulated, non-spore forming, flagellated rod belonging to 
the family Enterobacteriaceae (Garrity et al., 2004). The colonies vary from flat, round, 1-2 
mm size with smooth edges on blood agar, irregular edge shape and 1mm size when cultured 
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on deoxycholate agar. They reveal different colonial appearance depending on the selective 
and differential agar used. 
2.3.3 Pathogenesis and clinical manifestations 
Infections caused by P. shigelloides are divided in two main groups: gastrointestinal 
infections and extra-intestinal infections. It is regarded as a pathogen causing mainly 
gastrointestinal infections. It subsequently enters the human intestinal CaCO2 cells in vitro 
through phagocytic-like process. It was found that live bacteria escape from cytoplasmic 
vacuoles (Theodorpoules et al., 2001) and induce apoptic cell death (Tsugawa et al., 2005). 
Several reports have implicated that the organism as a cause of diarrheal disease in humans 
and animals (Famer et al., 1992, Ndip et al., 1995). Patients present a watery or secretory 
diarrhea but some have a more invasive dysenteric illness. Human infections due to this 
bacterium are mostly water borne, are strongly associated with drinking water. P. shigelloides 
infections occur in summer months and correlate with environmental contamination of 
freshwater. Gastroenteritis is usually a mild self-limiting disease with fever, abdominal pain, 
diarrhea and vomiting. Symptoms occur 20-24 hours after eating contaminated water and 
food (Ueda et al., 1999). Extra intestinal infections have included meningitis or 
meningocephalitis, bacteremia, wound infections, cellulitis and congenital endophthalmitis. 
2.3.4 Laboratory diagnosis 
It is identified by common bacteriological analysis, serotyping, genotyping and antibiotic 
sensitivity testing (Winn et al., 2006; Chen et al., 2007). The isolation and identification of 
this bacterium from samples depend on the screening of colonies for oxidase and indole 
positivity as well as appropriate use of selective and differential media (Krovacek et al., 
2000). The specimens can be cultured on MacConkey agar and after incubation the suspected 
colonies of P. Shigelloides are tested for cytochrome activity (Obi et al., 2007). As compared 
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to other phenotypic methods, serology has been used more successfully for distinguishing 
different strains. Serotyping schemes based on Somatic (O) and flagella (H) antigens are two 
main majors used. Different commercial kits such as TTE-AS and the API 20E can also be 
used for identification of this bacterium (Krovacek et al., 2000). The use of molecular 
techniques in genotyping bacteria has increased. Currently, different DNA based methods 
have been introduced as routine analysis in clinical laboratories. DNA based techniques such 
as repetitive extragenic palindromic-PCR (REP-PCR), enterobacterial repetitive intergenic 
consensus (ERIC-PCR) and random amplified polymorphic DNA (RAPD) are used 
(Gonzalez-Rey et al., 2003; Olive and Bean, 1999; Shigematsu et al., 2000). 
2.3.5 Epidemiology 
In an evaluation of P. shigelloides in animals, 55 cases were reported which represented 
1.21% of the 4.552 samples examined. However, 60% of the strains were isolated during 
investigations of the deaths or disease of animals (Bardon, 1999). Cats ranked first among 
animals from which P. shigelliodes were isolated. Aquarium fishes and trouts presented a 
high percentage of P. shigelloides cases. P. shigelloides is extensively distributed in the 
environment (Saterno et al., 2007).  The primary reservoir for this bacterium is aquatic 
environment such as fresh and estuarine water, animals such as goats, swine, cats, monkeys, 
snakes, toads and vultures. It can also be isolated from the gut of several animals and human 
faeces (Ramalivhana et al., 2008), numerous animals such as fish, birds and insects. Isolation 
of this organism has been reported mainly in tropical and subtropical countries (Gonzalez et 
al., 2003). Studies in Africa have shown that P. shigelloides is globally distributed (Obi et al., 
1995; Svenungsson et al., 2000). Isolation of Plesiomonads from a lake situated North of 
polar circle has been reported (Gonzalez-Rey et al., 2003). It has also been isolated from 
clinical specimens such as cerebrospinal fluid, wounds and the respiratory tract (Evgeny et 
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al., 2011).  The organism may be transmitted  through unsanitary water, which has been used 
as a drinking water, recreational water or water used to rinse food that are consumed without 
boiling them. It is also transmitted by oral-faecal route (Moussa et al., 2010). 
2.3.6 Treatment  
Most of the P. shigelloides strains are resistant to a broad-spectrum of penicillins, including 
ampicillin, piperacillin, ticarcillin, carbenicillin, azlocillin, ticarcillin and others (Stork and 
Wiedemann, 2001). Results of various studies show that P. shigelloides is naturally resistant 
to a diversity of Beta-lactams. P. shigelloides strains can be resistant to other 
aminoglycosides. Plesiomonads can be sensitive to cephalosporins (except cefoperazone, 
ceftazidime and cerfepime), carbapenems, trimethoprim + sulfamethoxazole, nalidixic acid, 
chloramphenicol and quinolones (Stock and Wiedemann, 2001). Trimethoprim resistance is 
mediated by dfr gene that encodes resistant dihydrofolate reductase (Aarts et al., 2006; 
Schwarz et al., 2006).  Strains resistant to chloramphenicol were also detected (Wong et al., 
2000). 
2.3.7 Prevention and control 
The risks of P. shigelloides infections may be reduced by avoiding consumption of raw or 
undercooked shellfish particularly during warmer months (Shock et al., 2009). Control in 
food by chill storage and moderate salting or acidifying conditions will prevent the growth of 
the organism. Hands should be washed with clean running water, educating visitors regarding 
animal contact in public setting and avoiding of eating, drinking and placing things in the 
mouth after animal contact can help in controlling diseases caused by the organism (CDC, 
2011). 
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2.4 Salmonella typhimurium 
2.4.1 Brief History  
Salmonella organisms were first isolated from infected pigs in 1885 by Theobald Smith. The 
genus Salmonella was named after Daniel Elmer Salmon, an American pathologist who 
discovered it in 1885. 
2.4.2 Morphology 
Salmonella typhimurium is a gram-negative, non-spore bacillus, motile with peritrichous 
flagella (Yan et al., 2004). The organism occurs as single cells or in short chains and the fully 
matured cells average size of 2-3 µm.The outer membrane consists of lipopolysaccharide 
(LPS) layer which surrounds the thin peptidoglycan layer, which makes it a gram negative 
organism (Quintela et al., 1997). 
2.4.3 Pathogenesis and clinical manifestations 
S. typhimurium is the most common serovar causing human food-poisoning in some parts of 
the world (Casadevall et al., 2001). Definitive Type (DT) 104, is a particularly virulent form 
of Salmonella typhimurium. It has been reported as world health problem (Helms et al., 2005) 
and its spreading has been associated with intensive use of antibiotics in human medicine and 
agricultural field (Threlfall, 2002). As pathogens, they have developed complex virulence 
mechanisms to evade host defence mechanisms (Casadevall et al., 2001). When the bacterial 
cells enter the epithelial cells lining the intestines, they cause host cell ruffling which 
temporarily damages the microvilli on the surface cells (McCormick et al., 2007). Its toxicity 
is due to an outer membrane consisting of lipolysaccharides (LPS) which protect the bacteria 
from its environment. Pathogenesis begins when S. typhimurium enters the body and if 
contaminated food is ingested. After ingestion, colonization takes place in the ileum and 
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colon as S. typhimurium invaders, grow and multiply within the lymphoid follicles and 
endothelium (Hendrieksen et al., 2004). Virulence factors allow the microbe to invade the 
cells, replicate intracellulary and if possible it disseminates the toxin. Toxin injected by 
Salmonella typhimurium works to inhibit the innate immune system by virtue of threonine 
acyltransferase activity and requires binding to eukaryotic target cell (Mittal et al., 2010). 
It is an important cause of morbidity and mortality in humans and animals, with S. enterica 
serovar Typhimurium becoming an emerging problem (Abouzeed et al., 2000; Hendriksen et 
al., 2004; Smith-Palmer et al., 2003). It causes gastroenteritis in humans and other 
mammalian species (McClelland et al., 2001).  Salmonella infections are often fatal in the 
elderly, young and people with depressed immune systems. When bacterial cells enter 
epithelial cells lining the intestines, they cause host cell ruffling which damages the microvilli 
on the surface of the cell temporarily (McCormick et al., 2007). Salmonella infections usually 
resolve in 5-7 days and many times require no treatment unless the patient is severely 
dehydrated or infection spreads from intestines. In mice, this organism cause symptoms 
resembling typhoid like fever (Everest et al., 2007). Although the organism does not cause 
the clinical disease in pigs, subclinical infections constitute an important food-safety problem 
throughout the world (Kranker et al., 2003). The disease is characterized by diarrhea, 
abdominal cramps, vomiting and nausea which generally last up to 7 days. The infection can 
spread from the intestines to the blood stream as well as other body sites and cause death if 
the infected person does not receive treatment early ( CDC, 2011).  
2.4.4 Laboratory diagnosis  
Diagnosis is based on culture of the organism from clinical specimens such as blood and 
faeces to specifically isolate and identify Salmonella from patient specimens. These culture 
plates are observed for the presence of bacterial colonies which are further tested using 
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biochemical tests. Biochemical tests are confirmation tests that help identify the specific 
species and strains of Salmonella species by observing their ability to ferment sugars, 
decarboxylate amino acids and utilize citrate (Fraser et al., 1999). Since culture takes time to 
identify the organism, serological tests such as agglutination test can give results in 1-2 hours 
and these tests are reliable. A small amount of serum is obtained from a patient’s blood 
sample and mixed with Salmonella antigens on a slide. A positive test is indicated by the 
formation of clumps (Rao et al., 1999). Rapid immunological identification and confirmation 
test based on latex agglutination, enzyme immunoassay (EIA) as well as enzyme-linked 
immunosorbent assay (ELISA) have been developed for Salmonella. Molecular methods are 
also available, such as DNA hybridization and PCR assays for the identification of 
Salmonella typhimurium in food and environmental samples (Correa et al., 2006). Pulsed- 
field gel electrophoresis, phage typing and plasmid profile analysis are other methods used 
for characterizing this bacteria (Torpdahl et al., 2007; Corbett- Feeney et al., 1998).  
2.4.5 Epidemiology 
Salmonellosis is an important medical problem causing food-borne diseases with an 
estimated 1.4 million illnesses and 500 deaths occurring annually (Jammy et al., 2008).  S. 
typhimurium remains a common cause of bloodstream and focal infections in sub-Saharan 
Africa for adults and children with HIV infection, malaria and malnutrition. Salmonella 
enterica serovar Typhimurium definitive phage type 104 (DT104), is the most well known, 
multi-resistant strain which disseminated globally (Hancok et al., 2000). This bacterium has 
been reported in 41 states of the USA since April 2009; in this report infected individuals 
ranged from less than 1 year to 67 years of age and fifty one percent of patients were females. 
Among these ill people, 30 % were hospitalized but no death cases were reported (CDC, 
2010). S. typhimurium was isolated in the 1980s in Japan and spreading occurred widely in 
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food-producing animals and it was among the five serovar found frequently in Salmonella 
foodborne illness in Japan between 2006-2010 (Sameshma et al., 2010). Studies have 
indicated that more than 80% of all salmonenollosis cases occur individually rather than as 
outbreaks. S. typhimurium organisms are common inhabitants of the gastrointestinal tracts of 
all animals, including cattles (Kunze et al., 2008). This can lead to mortality and morbidity as 
well as a disease burden worldwide (Cobum et al., 2007).  Animal products are the main 
vehicles of salmonellosis due to the ability of salmonellae to survive in meat and animal 
products that are not thoroughly cooked or not properly handled (Hariharan et al., 2000). It is 
readily transmitted through the faeces of people or animals. S. typhimurium can survive in the 
environment and may spread from farm through exchange of livestock, wildlife or runoff 
from fields (Akoachere et al., 2009).  There have been reports about commercial chicken 
layers being infected by S. typhimurium DT104, followed by problems in oral and aerosol 
routes. Most human cases are foodborne and spreading can occur mainly by consumption or 
handling of meat, consumption of unpasteurized milk and untreated water, however non-
foodborne infections can occur during contact with animals, contaminated water or 
environment (Besser et al., 2000; Schiellerup et al., 2001). 
2.4.6 Treatment 
The patient can be treated with ampicillin, gentamicin, amoxicillin, sulfamethoxazole or 
ciprofloxacin. The length of treatment varies depending on the extent of a patient’s illness 
and can range from 14 days for enteric fever and 6 weeks with bacteremia (Mayo, 2007). 
Some Salmonella bacteria have become more resistant like S. typhimurium DT 104 which is 
multidrug resistant to five antimicrobials: ampicillin, chloramphenicol, streptomycin, 
sulphonamides and tetracyclines. Although DT 104 is presently the dominant resistant clone 
of S. typhimurium, many other phages such as phage type (D29, 04, 193 and D204 C) of this 
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serovars have been associated with multidrug resistance (Sanchez et al., 2002). Moreover, 
new strains with resistance to additional antibiotics such as trimethoprim and 
fluoroquinolones are beginning to emerge. The emergence of Salmonella strains to first line 
therapy and increased minimum inhibitory concentrations of second generation of quinolones 
is a serious problem which make treatment ineffective (Birosova et al., 2009; Ricci et al., 
2009). This multidrug resistance have posed a major problem in the treatment of 
complications resulting from these Salmonella infections. 
2.4.7 Prevention and control 
Prevention depends on good food processing practices, proper refrigeration and adequate 
good hand-washing practises. Food should be thoroughly cooked; hands, surfaces, cutting 
boards and dishes should be washed with hot soapy water before handling food. Control of 
drug resistant Salmonella strains, is efficiently achieved by reducing the use of 
antimicrobials. Prevention of the infection can be done if people working in the microbiology 
laboratory can wash their hands properly before any contact with young children or baby 
bottles. Food, drinks or personal items such as keys or cell-phones should not be touched 
while working with microorganisms in the laboratory. Stationary such as notebooks, pens and 
other items should not be taken out of the microbiology laboratory and protective uniform 
such as lab-coats should be left in the laboratory after working (CDC, 2011). Control can be 
achieved by training the students and employees using the laboratory for biosafety practices. 
Educating people about the symptoms of Salmonella infection such as diarrhea, abdominal 
cramps and other related symptoms to seek medical attention quickly can help eradicate 
problems associated with salmonellosis. 
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2.5 Medicinal plants as complementary and alternative therapeutic options 
There is a search for phytochemicals from medicinal plants which can be developed for the 
treatment of infectious diseases especially when there is such an emergence of drug resistant 
microorganisms (Ncube et al., 2008; Anam et al., 2010). Medicinal plants are successful 
natural sources for the treatment of various infectious diseases of human. Scientists are 
focusing on discovering natural compounds from medicinal plants, with the aim of 
introducing new drugs which will be more effective than those available in the market 
(Parekh et al., 2006). Recent research has focused on natural plant product as alternatives for 
existing drugs for curing diseases in developing countries (Aiyegoro et al., 2007). They have 
formed the basis of sophisticated traditional medicine and make an excellent lead for new 
drug development (Newman et al., 2000). They are a good choice as they have less side 
effects, less expensive and effective against broad spectrum drug resistant microorganisms 
(Vermani et al., 2002; Pareck et al., 2005; Motamedi et al., 2010).  
 Plants used in traditional medicine contain a vast array of substances that can be used to treat 
chronic and infectious diseases (Shrisha et al., 2011). These chemical constituents have great 
potential for medicinal use and both traditional healers and pharmaceutical drug companies 
exploit them (Magwa et al., 2008). Medicinal plants have been used as an ancient tradition 
especially where modern drugs are not affordable or inaccessible (Njume et al., 2009). Even 
today, plants are the most exclusive source of drugs for the majority of the world and people 
in developing countries especially use traditional medicine for their primary health care 
(Palombo et al., 2001). The world health organization has reported that about 80 % of the 
world’s population is depending on traditional medicine (WHO, 1993). Herbal remedies 
continue to play a role in the cure of diseases (Tabuti et al., 2003).  
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Commercially proven drugs used in modern medicine were initially used in crude form in 
traditional folk healing practices. The amount of active components in crude extracts from 
medicinal plants small or diluted, when fractionated become concentrated and therefore show 
activity (Adeniyi et al., 2004). Medicinal plants are believed to be an important source of new 
chemical substances with potential therapeutic benefits. Many plants in Africa such as 
Garcinia kola have been investigated for their chemical components and some isolated 
compounds have been shown to possess interesting biological activity (Ezeifeka et al., 2004; 
Sibanda et al., 2008; Njume et al., 2011). 
2.6 Garcinia kola 
Garcinia kola is a species of flowering plant belonging to the family Guttiferae. It is found 
mostly in Central and Western Africa; in countries such as Cameroon, Benin, Democratic 
Republic of Congo, Ivory Coast, Gabon, Ghana, Liberia, Nigeria, Senegal and Sierra Leone 
(Eyog-Matig et al., 2007). This plant has a popular acronym “wonder’’ plant among the 
South-Western Nigerian people because every part of it has been found to be of medical 
importance (Iwu et al., 2002). It consists of fruits, leaves, roots, barks, stems and twigs and 
an average of four seeds is contained in a fruit. All parts of the plant are used in traditional 
medicine for various therapeutic purposes. The fruits are redish or yellowish in colour  and 
each  fruit contain two to four seeds and pulp that have a sour taste (Nzegbule and Mbakwe, 
2001; Adesanya et al., 2007). The seeds are smooth, oval shaped with yellow pulp and 
covered with a brown seed coat. They have been reported to possess antibacterial activity, 
antidiabetic, antiviral and antihepatotoxicity potentials (Farombi et al., 2002; Akoachere et 
al., 2002).  They are used to prevent or relieve colic pains, cure head and chest colds (Iwu, 
1993).  Traditional cough mixture is made by mixing dried and ground seeds with honey 
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(Odebunmi et al., 2009). This plant is also known in commerce as “bitter kola” and when the 
seed is chewed, a bitter astringent and resinous taste comes out of it.  
The mechanical cleansing effect and antimicrobial substances of the seed are seen as major 
beneficial effects of chewing the nut (Han et al., 2005).  The seeds are chewed raw with both 
the pulp and can be chopped and steeped in water. They are believed to clean the digestive 
system, without side effects such as abdominal problems (Odebunmi et al., 2009).  
Traditionally the seeds are chewed to stimulate the flow of saliva (Leakey, 2001); and are 
also consumed as snack in West and Central Africa. The seed is a highly valued ingredient in 
African ethnomedicine because of its varied and numerous uses which are social and 
medicinal, making the plant essential in folk medicine (Igwe et al., 2007). 
2.7 Solvents for plant extraction 
The type of solvents used has an effect on the nature of compounds extracted and the 
resulting bioactivity of the extract (Dogruoz et al., 2008; Eloff et al., 2008). This clearly 
implies that polarity of solvents (non-polar, polar and less polar) play a vital role in the 
extraction of bioactive compounds, which influence the antimicrobial activity (Bizimeya et 
al., 2002; Parekh et al., 2006; Ndip et al., 2007).  It is important for the efficiency of 
extraction to be optimized in order to ensure that many potential active constituents are 
extracted as possible. The rate of extraction, quantity extracted, handling of extracts, toxicity 
of solvent are some factors that need to be evaluated in order to ensure the value of a solvent. 
A variety of solvents is applied in the extraction of antimicrobial compounds (Masoko et al., 
2007).  
A study reported that methanol extract of the rhizome and leaves had better average activity 
against all tested organisms, while hexane extract had no activity (Masoko et al., 2008). 
Petroleum ether and methanolic extract of the leaves of Cassia occidentalis was effective 
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against E.coli at a concentration of 400 mg/mL with 5 - 11 mm inhibition zone, respectively 
(Vedpriya et al., 2010). Water is a universal solvent used and is usually used in preparation of 
folkloric medicine (Das et al., 2010). Natural products such as pigments and bioactive 
components are soluble in water which point out high yield of extract; while some solvents 
are only selective for certain bioactive compounds. This has been associated to a better 
solubility of active agents; xanthones, benzophenones and flavonoids especially biflavonoid 
type GB1 (Nwaokorie et al., 2010). In most studies water extract demonstrated weak activity 
(Doughari et al., 2007; Igbinosa et al., 2009; Sanjay et al., 2010). A study reported that 
acetone is a good solvent for extraction; and that it is usually preferred because of its ability 
to extract polar and non-polar components (Samie et al., 2005; Masoko and Eloff, 2006; 
Adefuye et al., 2011)..  
It was also reported that n-hexane extract of G. kola seeds showed best activity against five 
different Vibrio species (Okoh et al., 2011). Ethyl acetate extract showed a broad spectrum 
activity against gram - positive and gram - negative organisms (Adefuye et al., 2011). The 
study of Rajasekaran et al. (2008) exhibited ethanol and chloroform leaf extracts of Aegel 
marmelos, showing maximum inhibition against both gram-positive and gram-negative 
bacteria. This study was carried out with ethyl acetate, ethanol, methanol, acetone and 
distilled water with a view to find out the potentiality of G.kola seeds. It has been found that 
organic solvent extracts revealed the promising antibacterial activity (Parker et al., 2008; 
Njume et al., 2011). 
2.8 Phytochemical constituents 
Plants derived preparations and isolated phytochemicals may be potentially useful in the 
treatment of infectious diseases (Ncube et al., 2008). A number of compounds with in vitro 
antibacterial activity have been isolated from the extracts of this seeds. Phytochemical 
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analysis of the extracts of G. kola seeds have shown that they contain reasonable amounts of 
phenolic compounds including biflavonoids (GB-1, GB-2), xanthones and benzophenones 
(Okoko et al., 2009; Okunji et al., 2007). The wide spectrum of these organic compounds 
confer some anti-microbial activities against gram - negative and gram - positive bacteria. 
The therapeutic activity has been attributed to flavonoids, which are the dominant compounds 
and some new biflavonoids still continue to be identified along with such mixtures of 
phenolic compounds, related triterpenes and tannins (Han et al., 2005; Adeboye et al., 2006). 
The biological activities of flavonoids include action against allergies, inflammation, free 
radicals and hepatoxins (Tarishma et al., 2002). 
Some plant secondary metabolites such as alkaloids, phenols, tannins, glycosides, terpenoids, 
saponins, and steroids have been implicated in their ability to inhibit the formation of pro-
inflammatory signalling molecules (Polya et al., 2000). The phenolic compounds, when 
present at high concentration, act as a protoplasmic poison penetrating and disrupting 
bacterial cell wall in addition to precipitating cell proteins (Rubino et al., 1991). Saturated 
fatty acids (myristic, pentadecanoic, palmitic, margaric, stearic, arachdic, behemic); 
monosaturated fatty acids [ (myristoleic, palmitoleic (trans), palmitoleic (cis), oleic (cis), 
vaccenic (cis)]; polysaturated fatty acids ( linoleic, eiscosadienoic, polyenes) and essential 
amino acids (arginine, aspartic acid, glutamic acid, serine, histidine, proline, glycine and 
alanine were reported to be found in G. kola seed and hulls (Afolabi et al., 2006).  The seeds 
have also been found to contain 10% carbohydrate, 10 % crude fat, 5 % protein and sodium 
(Agyili et al., 2006). Two chromanols: garcionic and garcinal together with tocotrienol have 
been reported (Terishma et al, 2002). The seeds have also been reported to contain 
phlobaphenes, anthrocyans red pigment, betaine, protein and starch (Alolaiye et al., 2009).  
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                                       CHAPTER THREE 
                          MATERIALS AND METHODS 
3.1 Bacterial strains 
Standard strains of the following organisms were used in this study. They included: 
Streptococcus pyogenes (ATCC 49399), Staphylococcus aureus (NCTC 6571), Plesiomonas 
shigelloides (ATCC 51903) and Salmonella typhimurium (ATCC 13311). These organisms 
are human pathogens and are leading causes of hospital and acquired infections. They were 
selected based on their prevalence and increasing trend of resistance to antibiotics (Tolan, 
2008). 
3.2 Resuscitation of bacterial strains 
Bacterial isolates of test organisms were obtained from stock cultures maintained at the 
Department of Biochemistry and Microbiology, University of Fort Hare. Resuscitation of the 
cultures was done by inoculating S. pyogenes and S. aureus on Mueller Hinton and P. 
Shigelloides and S. typhimurium on Salmonella - Shigella agar and plates incubated at 37°C 
for 24 hours. They were frequently subcultured on Mueller Hinton or Nutrient agar slants and 
stored in the refrigerator. 
3.3 Preparation of plant extract 
Garcinia kola seeds were purchased from a local market in Cameroon. They were blended 
into powder and kept in an air-tight container for further use. The extracts of the seeds were 
prepared in accordance with the method of Basri and Fan (2005). One hundred grams of the 
powdered seeds were steeped in 500 mL of ethyl acetate, ethanol, methanol, acetone and 
distilled water for 24 hours with 140 rev/min shaking. The resulting extracts were filtered 
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using Whatman No 1 Filter paper. The extracts were further concentrated to dryness under 
reduced pressure at 37 °C using a rotary evaporator (Strike 202 Steroglass, Italy) to remove 
the solvents. 
3.4 Antimicrobial Susceptibility testing 
The sensitivity testing of G. kola seeds extract was determined using the agar well diffusion 
method as previously described (Irobi et al., 2000) with minor modifications. The bacterial 
isolates of S. aureus, S. pyogenes, P. shigelloides and S. typhimurium were grown in Mueller 
Hinton agar. The medium was poured into plates and allowed to solidify. The plates were 
swabbed with cotton wool impregnated with the organisms prepared at 0.5 McFarland 
standard. Wells were bored into the agar medium using sterile 6mm cork borer and labelled. 
Five holes were bored in one plate. The first three wells were filled with solution of the 
extract at concentrations of 200, 100 and 50mg/mL. The other two wells were filled with a 
positive control (ciprofloxacin) and negative control [dimethylsulfoxide (10 % DMSO)]. The 
plates were then allowed to stand for 20 minutes to allow proper diffusion of the solution into 
the medium before incubation. They were then incubated at 37 °C for 24 hours. 
Antimicrobial activity was evaluated by measuring the zones of inhibition against the test 
organisms. The experiment was replicated two times. 
3.5 Determination of Minimum Inhibitory Concentration (MIC90)  
The microdilution method was employed to determine the MIC of the plant extract that gave 
best activity using 96 well microtitre plates as previously described (Njume et al., 2011). A 
twofold serial dilution was carried out. Two to three colonies of S. aureus, S. pyogenes, P. 
shigelloides and S. typhimurium were grown in BHI broth. Approximately 20µL of each 
bacterial suspension was added to 180 µL of wells containing extract (methanol) which 
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showed best antimicrobial activity. Control wells were prepared by adding 100 µL of 
ciprofloxacin at a concentration of 1.25 mg/mL. The plates were incubated overnight at 37 °C 
and read with an automatic enzyme-linked Immunosorbent assay microplate reader (Model 
680, Bio-Rad, Japan). The MIC90 was taken as lowest concentration of the test extract 
resulting in inhibition of 90% of bacterial growth. 
3.6 Determination of Maximum Bactericidal Concentration (MBC) 
The MBC was determined using the method of Vila et al. (2010) with little modifications. 
Approximately, 2µL of the sample from MIC assay was spread onto freshly prepared agar 
plates and incubated at 37 °C for 24 hours in order to determine the MBC. S. pyogenes, S. 
aureus, P. shigelloides and S. Typhimurium were subcultured on Mueller Hinton agar. This 
also included the positive control; the experiment was done separately for all organisms. The 
plates were monitored for the presence of bacterial growth after 24 hours of incubation. The 
MBC were taken as the lowest concentration that did not allow bacterial growth on the 
surface of the agar plates. 
3.7 Phytochemical and Antimicrobial analysis 
3.7.1 Thin Layer Chromatography (TLC) 
Thin Layer Chromatography was used to analyse the chemical constituents of the G. kola 
seeds extracts using aluminium-backed TLC plates (Merck, silica gel 60 F254) according to 
the method of Kotse and Eloff (2002). The plates were spotted with 50 and 100mg/mL of 
methanolic extract of G. kola seeds. The TLC plates were developed with three eluent 
systems i.e.: ethyl acetate/methanol/water (40:5.4:5): [EMW], chloroform/ethyl 
acetate/formic acid (10:8:2): [CEF], benzene/ethanol/ammonium hydroxide (18:2:0.2): 
[BEA]. Development of the chromatograms was done in a closed TLC chamber containing 
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solvent mixture and shaken. The chamber was kept covered in order for evaporation not to 
change the composition of the developing solvent mixture. A line was drawn with a pencil 
were migration of the extract had ended on the TLC plate. The plates were sprayed with 
vanillin solution (0.2 g vanillin + 28 mL of methanol +1mL of Sulphuric acid) and allowed to 
dry for 5 minutes; the chromatograms were heated at 100°C and allowed for optimal colour 
development. The spots or bands were visualized in broad daylight and also under ultraviolet 
light at 302 and 365 nm. The following formula was used to measure the retention factor (R f) 
which is distance the compound travels to the distance the solvent travels. 
Rf =
                             
                        
 
3.7.2 Antimicrobial activity assay by bioautography 
The method developed by Masoko and Eloff (2005) was used to determine active 
compounds. The plates developed in the three different mobile systems used: CEF, BEA and 
EMW were dried for up to a week at room temperature under a stream of air to remove the 
remaining solvent. The plates were sprayed with concentrated bacterial cultures and 
incubated in a humidified container at 37°C overnight. The following day the plates were 
sprayed with 0.2 mg/mL solution of p-iodonitrotetrazolium violet (Sigma®) (INT). 
Purple/pink colour indicated an area were the organism grew and clear zones indicated the 
absence of the organism due to the presence of compound(s) that inhibited the growth of 
tested microorganisms. Rf  of the zones on the plates were compared with that on the 
reference plates to find the Rf  of the active compound.  
3.8 Column Chromatography 
Column Chromatography was used as a purification technique. The mixture of compounds to 
be purified was dissolved in small amount of the appropriate solvents as earlier described by 
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Kotse and Eloff (2002). A 40cm long x 2.5cm diameter glass column was packed to a height 
of 31cm with a slurry of silica gel 60; particle size 0.063 - 0.2mm/ 70 – 230 mesh (Merck, 
Germany). The column was quilibrated with 100%  chloroform for 30 minutes. Five grams of 
the methanolic extract of the seeds were mixed with 10g of silica gel powder and ground to 
very fine particles. A dry loading method was applied. The mixture was dissolved in 
chloroform and put under extreme air temperature until the solvent evaporated leaving only  
dry powder. The mixture was then loaded onto a silica gel column equilibrated first with 
chloroform. The combination which gave good activity, CEF (10:8:2) was then used to elute 
the column; fractions (200 mL) were collected in bottles and coded C for fractions collected 
in chloroform and CEF for Chloroform/Ethyl Acetate/Formic acid. They were concentrated 
on a rotary evaporator (Strike 202 Steroglass, Italy) to remove excess solvents at a reduced 
pressure. Fractions were dried and weighed to determine the mass extract and stored in air 
tight containers for further bioassay. 
 
3.9 Determination of Minimum Inhibitory Concentration (MIC90) of    
      fractions. 
The MIC90 of the fractions was determined by micro-broth dilution method performed in 96-
well plate as previously described (Njume et al., 2011) and active fractions were further 
analyzed on TLC to deternine the purity. Test fractions were prepared at a concentration of 
2.5 mg/mL. Two to three colonies of S. aureus, S. pyogenes, P. shigelloides and S. 
typhimurium were grown in BHI broth. Approximately 20µL of each bacterial suspension 
was added to 100 µL of fraction that contain culture medium. Two-fold dilutions of each 
fraction was made in the test wells in BHI broth. Control wells were prepared with culture 
medium only  and bacterial suspension plus broth. Ciprofloxacin was used as a positive 
control at 1.25 mg/mL. An automatic ELISA microplate reader (SynergyMx,Biotek
R
 USA) 
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adjusted to 620 nm was used to measure the absorbance of the plates before and after 
incubation at 37
o
C. The absorbencies were compared to detect an increase or deacrease in 
bacterial growth. The lowest concentration of the fraction  resulting in inhibition of  90% 
bacterial growth was recorded as the MIC90. 
3.10 Gas-Chromatography/Mass-Spectrometry (GC-MS) 
 The chemical constituents of fractions were analysed by GC/MS using a Hewlett-Packard 
HP 5973 mass spectrometer interfaced with an HP-6890 gas chromatograph with an HP5 
column (30 m ×0.25 mm i.d, 0.25 µm film thickness) and MS detector. Helium was used as a 
carrier gas. The oven temperature was set at 70◦C for 2 minutes to 325◦C at a temperature of 
4◦C per minute. The final temperature was 240 ◦C. The samples were injected into GC-MS 
inlet port using a syringe. The ion source was at a temperature of 250◦C and electron 
ionization at 70 Ev.  The compounds were identified based on the match with their mass 
spectra and retention indices with those of the Wiley 275 library (Wiley, New York, NY) in 
the computer library and literature. 
3.11 Statistical analysis 
Analysis was performed using SPSS version 18.0 (Illinois, USA, 2009). The one way 
ANOVA test was used to determine if there was any statistically significant difference in the 
diameter of zones of inhibition of the plant extracts and ciprofloxacin; the MIC of the most 
active extract (methanol), fractions and positive control (ciprofloxacin). P values < 0.05 were 
considered significant. 
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                                                CHAPTER FOUR 
                                                RESULTS 
4.1 Susceptibility testing 
The zones of inhibition (clear zones on agar) for all four organisms were measured in mm. 
All the extracts with the exception of water extract were active against the test organisms 
with inhibition zone diameters ranging from 0 - 24mm (Table 1). The methanol extract 
demonstrated a bigger zone diameter of 24mm for S. pyogenes (P < 0.05). Positive control 
zones ranged between 23 - 31mm. Extract considered very active in this assay was further 
evaluated to determine the MIC.  
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Table 1: Antibacterial activity of the seed extracts of G. kola and ciprofloxacin. 
                                                                  Zones of inhibition (mm) at different concentration (mg/mL)                                           
 
Organism         Extract                 50mg/mL       100mg/mL    200mg/mL        Ciprofloxacin 
 
                        Ethyl Acetate        21                     23                 20                        25                                                                                                                                                                         
S.pyogenes      Acetone                 19                     22                 23                        24 
                        Ethanol                  19                     19                 22                        24 
                        Methanol               20                     24                 21                        23 
                        Water                     0                        0                   0                         25 
 
                        Ethyl Acetate        17                     17                 14                        26                                                                                                                                                                         
S.aureus          Acetone                 19                     19                 21                        24 
                        Ethanol                  18                     23                 20                        27 
                        Methanol               21                     22                 19                        23 
                        Water                     0                        0                   0                         24  
 
                        Ethyl Acetate        0                         0                   0                       30                                                                                                                                                                         
P.shigelloides  Acetone                0                        15                 12                      30 
                        Ethanol                 10                      19                 11                       31 
                        Methanol              18                       21                19                       30 
                        Water                     0                        0                   0                        31 
 
                        Ethyl Acetate         0                        0                   0                        30                                                                                                                                                                         
S.typhimurium Acetone                 16                     14                  0                         30 
                        Ethanol                   0                      18                 14                        29 
                        Methanol               17                     18                 15                        30 
                        Water                      0                       0                   0                         31 
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4.2 MIC and MBC determination  
The MIC and MBC were evaluated on the plant extract (methanol) that exhibited best activity 
against the test organisms. The MIC of the extract and ciprofloxacin ranged from 0.04 - 1.25 
mg/mL and 0.0012 - 0.0195 mg/mL, respectively while the MBC of the extract and 
ciprofloxacin ranged from 0.081 - 2.5 mg/mL and 0.0781 - 0.3125 mg/mL, respectively. S. 
pyogenes and S. aureus had the lowest MIC of 0.04 mg/mL (Table 2).  
                                                         
Table 2: MIC90 and MBC of methanol extracts of G. kola and ciprofloxacin on test 
organisms.   
 
Organism        MIC value of            MIC value of          MBC value of        MBC value of 
                        Extract (mg/mL)      ciprofloxacin          extract (mg/mL)     ciprofloxacin 
                                                         (mg/mL)                                                 (mg/mL)            
 
 
S.pyogenes         0.04                          0.0012                     0.081                       0.0781 
S.aureus             0.04                           0.0024                     0.25                        0.1563 
P.shigelloides    1.25                           0.0049                     2.5                           0.3125 
S.typhimurium   0.63                           0.0195                     1.25                         0.1563 
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4.3 Thin Layer Chromatography analysis of methanol extract of G. kola. 
The three solvents combination used were CEF (10:8:2), EMW (40:5.4:5) and BEA 
(18:2:0.2) at 50 and 100 mg/mL of methanol extract.  CEF separated more compounds, 
followed by EMW and BEA. Bands which were not seen on TLC plates in daylight were 
visible when viewed under ultraviolet light at 302 and 365nm (Figure 1 a - b). Most bands 
were visible in daylight with CEF plates while for BEA and EMW  the bands were visible 
when viewed under 365 nm UV. In BEA, compound 3 and 6 showed the highest Rf   value of 
0.12 and 0.32; compound 1 showed lowest Rf   value of 0.08 and 0.01 at 50 mg/mL and 100 
mg/mL, respectively. In CEF, compound 10 and 12 showed the highest Rf  value of 0.87 and 
0.88 whereas compound 1 showed lowest Rf     value of 0.09 and 0.08 at 50 mg/mL and 100 
mg/mL, respectively. In EMW, compound 9 and 10 showed the highest Rf   value of 0.75  and 
0.88 while compound 1 showed  the lowest Rf  value of 0.03 and 0.09 at 50 mg/mL and 100 
mg/mL, respectively. A good separation was observed at a concentration of 100 mg/mL 
(figure 1 a - c). 
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Table 3: Rf  values for the different systems at different concentrations. 
                                                                                               Solvent systems                                                                          
 
Compounds                                BEA                          CEF                                   EMW             
                                                    
                                             50       100mg/mL       50      100mg/mL              50      100mg/mL   
 
1                                          0.08           0.01           0.09        0.08                    0.03      0.09 
2                                          0.1             0.13           0.14        0.11                    0.08      0.16 
3                                          0.12           0.16           0.39        0.19                    0.11      0.19 
4                                          -                 0.22           0.5          0.39                    0.16      0.31 
5                                          -                 0.28           0.52        0.53                    0.31      0.49 
6                                          -                 0.32           0.53        0.55                    0.49      0.56 
7                                          -                  -                0.63        0.63                    0.56      0.64 
8                                          -                  -                0.72        0.64                    0.72      0.67 
9                                          -                  -                0.83        0.72                    0.75      0.76 
10                                        -                  -                0.87        0.83                      -          0.88 
11                                        -                  -                 -             0.85                      -            -             
12                                        -                  -                 -             0.88                      -            - 
          -, No Rf  values determined 
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Figure 1a: TLC plates showing separation of compounds for (EMW, BEA, CEF), viewed 
under 302 nm (UV). 
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Figure 1 b: TLC plates showing separation of compounds for (CEF, BEA, EMW), viewed 
under 365 nm (UV). 
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Figure 1c : TLC plates showing separation of compounds for (EMW, BEA, CEF), viewed 
after staining with vanillin. 
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4.4 Antimicrobial activity assay by bioautography 
The areas of inhibition coloured white/ light yellow were compared with the Rf   on the related 
spot on the reference plate. In CEF, active compounds against S. pyogenes were found at 
varying  Rf  values  (0.53, 0.64) , S. aureus (0.82) , P. shigelloides (0.63, 0.72, 0.85)  and S. 
typhimurium (0.53, 0.63, 0.55, 0.64) at  50 and 100 mg/mL, respectively. Compounds 
containing inhibitory potential in EMW for S. pyogenes were located in Rf  (0.30, 0.31),  S. 
aureus (0.56, 0.63), P. shigelloides (0.75, 0.76, 0.88) and S. typhimurium (0.52).  In BEA, 
inhibitory compounds were found at the origin for both S. pyogenes and S. typhimurium only. 
Most compounds having inhibitory effect were found in CEF chromatograms, followed by 
EMW and lastly BEA (Table 4). A very high inhibition was observed in chromatograms 
developed in CEF against S. typhimurium (0.63) and BEA against S. pyogenes at the origin 
(figure 2 a - b). 
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Table 4 : Inhibition of bacterial species by methanol extract using bioautography. 
 
                                              Methanolic extract 
Organisms                            a                                                    b                            Solvent system 
                         (50 mg/mL        100 mg/mL)        (50 mg/mL      100 mg/mL)                                                                              
 
S.pyogenes        0.53                      0.53                    +++               +++                        CEF     
                          0.64                      0.64                    +++               +++                        CEF 
                          0.30                      0.31                    +                    +                            EMW 
                          origin                   origin                  ++++            ++++                       BEA 
S.aureus             -                           0.82                     -                    +                            CEF   
                          0.56                      0.63                    +++               +++                        EMW 
                            -                           -                          -                    -                             BEA 
P.Shigelloides    0.63                      0.63                    ++                 ++                          CEF   
                           0.72                      0.72                    ++                 +++                        CEF 
                               -                        0.85                    -                    ++                          EMW 
                           0.75                      0.76                    ++                 ++                          EMW 
                              -                         0.88                    -                    ++                          EMW 
                              -                         -                          -                    -                             BEA 
S.typhimurium    0.53                      0.55                    ++                  ++                         CEF   
                           0.63                       0.64                   ++++              +++                       CEF 
                           0.52                      0.52                    ++                  +++                       EMW 
                           origin                    origin                 ++                  ++                         BEA 
 
a, Component Rf ; b, Degree of inhibition; Rf, Ratio of the distance travelled by compound to 
the distance travelled by solvent up plate; - , Component not active; +, slight inhibition ; ++, 
moderate inhibition; +++, high inhibition; ++++, very high inhibition; origin, spot on the 
TLC plate where the extract was initially applied. 
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 P. shigelloides      S. pyogenes             S. typhimurium 
 
Figure 2a: Bioautography of chromatograms developed in CEF solvent system showing  
                  clear zones of inhibition for P. shigelloides, S. pyogenes and S. typhimurium. 
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Figure 2b: Bioautography of chromatograms developed in EMW and BEA solvent systems  
                  showing clear zones of inhibition for S. aureus, P. Shigelloides and S. pyogenes.  
                  . 
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4.5 Column Chromatography analysis and MIC90 determination of    
      fractions. 
Approximately four fractions of 200mL of chloroform were collected, followed by eighteen 
fractions of Chloroform/Ethyl Acetate/Formic acid (CEF). Fraction CEF 4-6 and CEF 8-10 
were combined due to the presence of similar compounds showing same mobility or (Rf s)  on 
TLC profile. This yielded a total of sixteen major fractions including those collected from 
chloroform. CEF 3 and CEF 11 showed one band with Rf values 0.153 and 0.13, respectively. 
A maximum of three bands were observed on fractions analysed by TLC. Minimum 
Inhibitory concentrations of fractions were tested against all the organims. Lowest MIC 
values of 0.0012 mg/mL against S. pyogenes (compared favourably to that of ciprofloxacin), 
0.0006, 0.0195, 0.012 mg/mL for S. aureus, P. shigelloides and S. typhimurium, respectively 
(Table 5). CEF (1, 2, 3, 8 - 10, 11, 12) demonstrated bacterial inhibition against all the 
organisms tested. The MIC of the fractions ranged between 0.0006 - 2.5 mg/mL and that of 
ciprofloxacin between  0.0012 - 0.781 mg/mL. 
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Table 5: Rf  values of fractionated compounds and MICs in mg/mL against test organisms. 
Fraction        Rf  value of fractionated compounds                                                           MIC90  against test organisms 
                                                                                                               S.pyogenes                 S.aureus            P.shigelloides            S.typhimurium                                                                                                                  
C1                    0.008, 0.159, 0.31                                                             ND                             ND                       ND                            ND 
C2                    0.09, 0.12, 0.36                                                                 ND                             ND                       ND                            ND 
C3                    0.13, 0.17, 0.29                                                                 0.0195                        0.00781                ND                            ND 
C4                    0.156, 0.286, 0.294                                                           0.00871                      0.0195                  ND                            ND 
CEF 1              0.2, 0.366, 0.42                                                                 0.049                          0.0098                  0.625                         0.3125 
CEF 2              0.34, 0.4, 0.52                                                                   0.625                          0.024                    0.625                         1.25 
CEF 3              0.153                                                                                 0.1563                        0.0781                  0.0781                       0.1563 
CEF 4-6          0.13, 0.226, 0.3                                                                  ND                             0.024                    2.5                             2.5 
CEF 7              0.2, 0.33                                                                            0.625                          0.0049                  ND                            0.1563 
CEF 8-10        0.16, 0.306, 0.36                                                                0.0195                        0.024                    2.5                             2.5 
CEF 11            0.13                                                                                   0.049                          0.0006                  2.5                             0.012 
CEF 12            0.15, 0.18                                                                          0.3125                        0.635                    0.0781                       1.25 
CEF 13            0.13, 0.18, 0.28                                                                 0.0049                        0.024                    1.25                           ND 
CEF 14-16      0.15, 0.2                                                                             0.3125                        1.25                     1.625                         ND 
CEF 17            0.11, 0.38                                                                          0.0024                        0.049                    0.325                         ND 
CEF 18            0.12, 0.27                                                                          0.0012                        0.1563                  0.0195                       ND 
Ciprofloxacin                                                                                            0.0012                        0.0049                  0.012                         0.0781                           
C = Chloroform, CEF = (Chloroform: Ethyl Acetate: Formic acid), ND = Not Determined (value not within susceptible range) 
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4.6 GC-MS Analysis of fractions 
Three fractions CEF 3 (F3), CEF 11 (F11) and CEF 12 (F12) were analysed by GC-MS 
because they were more active and pure. Figure 3 (a, b, c) show chromatograms, which are 
plots of the total mass eluting from GC and detected by MS as a function of time. Each peak 
represents a discrete chemical compound. GC-MS chromatogram of CEF 3 (F3) showed 10 
peaks indicating the presence of 10 compounds (Figure 3a), with the highest peak of RT 
34.24 and lowest peak RT 29.89. The three major compounds present in CEF3 (F3) were  
Linoleic acid constituting a proportion percentage of 26.60 %, followed by Hexadecanoic 
acid (25.07 %) and 9-Octadecenoic acid (24.81 %); minor compounds were Hexadecanoic 
acid, methyl ester (0.73 %) and 9-Octadecanoic methyl ester (0.91%) (Table 6). Most 
compounds prevalent in CEF 3 (F3) were fatty acids. A different GC-MS chromatogram was 
shown in CEF 11 (F11) which had a single peak (RF 41.20) and 100 % area percentage of a 
single compound, 1, 2- Benzenedicarboxylic acid, a carboxylic fatty acid ester (Figure 3b). 
CEF 12 (F12) demonstrated 14 peaks, indicating the presence of 14 compounds (Figure 3c) 
with the highest and lowest peak (RT 40.34 and RT 37.76), respectively. The three major 
compounds present were 2.3 - Dihydro - 3, 5 - dihydroxy - 6 - methyl (24.16 %), 1- Butanol 
(15.72 %) and 9 - Octadecenamide (13.82 %) and minor compounds were Hexadecanamide, 
Amide (1.59 %) and cyclohexadecane (1.84 %). 
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       Figure 3a: GC-MS chromatogram of CEF 3 (F3) 
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Figure 3b: GC/MS chromatogram of CEF 11 (F11) 
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Figure 3c: GC-MS chromatogram of CEF 12 (F12) 
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Table 6:  Chemical compounds identified by GC-MS 
    Fraction        Peak               RT (mins)      Area %                 Compounds identified 
CEF 3 (F3)                 1                       29.89                  0.73                         Hexadecanoic acid, methyl ester     
                                     2                       30.42                  4.41                          Hexadecanoic acid, Palmitic acid                          
                                     3                       31.93               25.07                           Hexadecanoic acid, Palmitic acid            
                                     4                       31.22                  0.83                           Hexadenoic acid , ethyl ester           
                                     5                       33.19                  0.91                           9-Octadecenoic acid, methyl ester                                                           
                                     6                       33.71                  6.63                           Heptadecene –(8)-Carbonic acid             
                                     7                       34.10                26.60                           Linoleic acid 
                                     8                       34.24                24.81                           9-Octadecadienoic acid               
                                     9                       34.42                  2.62                           14-Pentadenoic acid 
                                    10                     34.53                   7.49                          Octadenoic acid, Stearic acid            
CEF 11 (F11)            1                      41.20                   100                           1,2-Benzenedicarboxylic acid, bis 
CEF 12 (F12)            1                        6.63                    2.31                          Formide, N, N-Diethyl  
                                     2                         8.45                 15.72                           1-Butanol                                                                                       
                                     3                          9.95                  3.03                           3-Isothiazolecarboxamide                
                                     4                        12.07                24.16                          2,3-Dihydro-3,5-dihydeoxy-6-methyl 
                                     5                        15.04                  7.06                           2,5-Di (hydroxymethyl)-furan       
                                     6                        30.78                12.91                          Hexadecanoic acid, Palmitic acid                             
                                     7                        33.94                  4.08                           9-Octadecanoic acid                                                                              
                                     8                        34.02                  1.84                           Cyclohexadecane        
                                     9                        34.36                  3.11                           Octadecanoic acid, Stearic acid 
                                    10                      34.68                   2.55                           n-tetradecanoic acid amide   
                                    11                      37.75                 13.82                           9-Octadecenamide 
                                    12                       38.11                  1.59                           Hexadecanamide, Amide 
                                    13                       40.34                  2.07                           3,4,8-Trimethyl-2-nonenal 
                                    14                       41.23                  5.76                           Di-(2-ethylhexyl) phthalate 
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                                  CHAPTER FIVE 
                              Discussion and Conclusion 
5.1 Discussion 
 Antimicrobial resistance is a major problem which the world is facing and is resulting in 
increased death rate. The multiple antimicrobial resistant bacteria cause severe problems that 
result in the complication of treatment of bacterial infections and this has been recognized by 
the World Health Organization (WHO, 2005). Antibiotics are used as chemotherapeutic 
agents and they were believed to lead in the complete eradication of infectious diseases 
(Rosina et al., 2009). Despite the progress made in introducing new antibiotics, emergence of 
drug resistant strains cause failure of infectious disease treatment (Matthias et al., 2000; 
Gibbons et al., 2005). It is believed that consumption of antibiotics in livestock, agriculture 
and poultry is one of the factors that has caused an increase in the development of drug 
resistance. Some farmers use antibiotics to make animals grow big and this application in 
animal and food production promotes the development of antibiotic resistance in humans; 
also the indiscriminate use of antibiotics by humans accounts for this. Studies have found that 
antibiotic resistance occur as a result of an intrinsic mechanism that prevents bacteria from 
destruction (McDonnell et al., 2001; Stacey et al., 2001). These bacteria usually do not have 
the structural cellular mechanisms that are needed in order for the antibiotic to act upon 
(Courvalin et al., 2006). New effective strategy is therefore necessary for the management of 
resistance bacteria: one of which includes medicinal plants. 
 It is estimated that more than two thirds of the world’s plant species have medicinal value 
(WHO, 2011); and about 80% of people rely on herbs for their medicines (Arunkumar et al., 
2009). Medicinal plants are believed to be an important source of new chemical substances 
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with potential therapeutic benefits (Eisner et al., 1990). They contain many biologically 
active compounds with medicinal properties and largely employed in developing countries 
(Ifeom et al, 2002). They produce a variety of natural products or secondary metabolites 
which are toxic in nature and are used as defence mechanism against microbial pathogens, 
insects, herbivores and other predators (Schafer et al., 2009; Bakkali et al., 2008). In addition 
to the production of intrinsic antimicrobial compounds, it has been hypothesized that plants 
also produce multi-drug resistance inhibitors which enhance the activity of antimicrobial 
compounds (Stermits et al., 2000). These active constituents react with other bacterial 
pathogens and inhibit their growth (Sermakkani et al., 2011). Compounds isolated from 
natural origin such as medicinal plants are believed to have less side effects, tolerated by 
patients and can be afforded by most people since they are sold at a cheaper, reasonable price 
(Vermani and Garg et al., 2002).     
G. kola plant has been investigated largely due to its diverse bioactivities. Ethyl acetate, 
ethanol, methanol, acetone and distilled water were the five solvents used in extraction of the 
G. kola seeds in this study. A concentration of 50, 100 and 200 mg/ mL of the dried extract 
was reconstituted for antimicrobial activity by dissolving extracts in 10 % DMSO (Njume et 
al., 2011). Methanolic extract of the seeds demonstrated good activity against all the 
organisms with the highest zone diameter of inhibition of 24 mm against S. pyogenes. The 
results for susceptibility testing of the extracts which are indicated in Table 1 confirms the 
results of previous studies, which reported that methanol is an efficient solvent (Eloff, 1998; 
Ezeifeka et al., 2004, Jayalakshmi et al., 2011; Vhagasia et al., 2011).  The water extract 
demonstrated poor activity in all the organisms since no clear zones of inhibition were seen 
on the agar plate; which is in line with previous findings (Eloff, 1988; Manetti et al., 2007; 
Nwaokorie et al., 2010). This is an indication that water was not a good solvent; this could 
probably be that compounds responsible for bioactivity were not soluble in distilled water. 
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The activity of the positive control was higher than that of plant extracts (P < 0.05), although 
the ethanol extract compared favourably with that of ciprofloxacin (positive control) against 
S. pyogenes. Although methanol extract showed activity against both Gram - positive and 
Gram - negative, the Gram - positives were more susceptible with greater inhibition zones; 
these findings agree with previously published reports (Ezeifeka et al., 2004; Jigma and 
Sumitra, 2006; Sibanda et al., 2008).  
The activity of the methanol extract against both gram-negative and gram-positive organisms 
was of great interest because a more profound activity of several extracts is usually expected 
against gram-positive bacteria. This has been explained by the difference in cell wall 
composition, with gram-negative being complex (Bhattarai et al., 2008; Vhagasiya et al., 
2011). The antimicrobial activity of G. kola seeds extracts showed a broad spectrum activity 
and this is in harmony with previous findings (Akinpelu et al., 2006; Adeboye et al, 2008; 
Njume et al., 2011). 
The MIC90 of the methanol extract was evaluated against all organims as it demonstrated the 
best antimicrobial activity in the general screening. The MIC values for the extract and 
positive control (ciprofloxacin) ranged between 0.04 - 1.25 mg/mL and 0.0012 - 0.0195 
mg/mL, respectively (Table 2). The MBC of the extract and ciprofloxacin ranged from 0.081 
- 2.5 mg/mL and 0.0781- 0.3125 respectively. The MBC values were higher than the MIC 
values. This suggests that the extract was bacteriostatic at lower concentration and 
bactericidal at higher concentration. S. pyogenes and S. aureus were the most sensitive 
bacteria tested, with the lowest MIC of 0.04 mg/mL. This results show that some medicinal 
plants can be potential sources of new antibacterial agents. 
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Plants contain oils or fats and these are found mainly in their seeds. These lipids are usually 
stored in the form of triglycerides. Essential oils produced by plants are not only used in 
agriculture or in food industries as food preservatives or additives, but also used 
pharmaceutically for their therapeutic activities in the treatment of various diseases (Vila et 
al., 2010).  The complexity of their chemical constituents is responsible for various biological 
activities. Linoleic acid, palmitic, and stearic acids are usually found in oil obtained from 
seeds. Palmitic acid is common saturated fatty acids reported to be found in plants and 
animals; and one of the major components of oil found in plants and their seeds. Linoleic acid 
is an organic compound that belongs to a group of essential fatty acids found in many oils 
produced by plants such as vegetables (Rogers et al., 2006). It cannot be produced in human 
bodies and therefore is acquired through diet. It is a carboxylic acid with 18-carbon chains 
and most seed oils are sources of this acid. It is regarded as one of the healthiest cooking oil 
and suitable for most cooking purposes. Studies have proved that it lowers the risk of 
cardiovascular disease (William et al., 2000; Penny et al., 2002). Stearic acid is the saturated 
fatty acid occurring in oils, vegetables and animals. It has an IUPAC name of Octadecanoic 
acid and is a carboxyl long hydrocarbon chain with carboxyl group at one end and methyl 
group at the other end.  
Success in isolating compounds from the plant material was largely dependent on the type of 
solvent combination used in the extraction process. CEF separated more compounds (10) at 
50mg/mL and 12 at 100 mg/mL, followed by EMW which separated 9 compounds at 50 
mg/mL and 10 at 100mg/mL. BEA separated fewer compounds, with 3 at 50 mg/mL and 6 at 
100 mg/mL. An interesting observation was noted at 100 mg/mL; most compounds were 
efficiently separated at this concentration. The total number of compounds extracted using 
different solvents is shown in Table 3. This implies that solvent with intermediary polarity 
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separated more active compounds. This findings correlates the findings of Masoko (2007), 
where the greatest separation was obtained using CEF.  
Bioautography was done in order to determine the position of compound(s) showing 
antibacterial activity. The plates for bioautography were run in duplicates, one set was used 
as the reference chromatogram and the other for antibacterial activity assay. The areas of 
inhibition were compared with the Rf of the related spots on the reference TLC plate. 
Bioautography revealed that the methanol plant extract had components with inhibitory 
effects against most of the organisms including the gram-negative organisms (Table 4). A 
very high inhibition (indicated by a clear zone) was observed in the chromatogram developed 
in CEF at Rf  (0.63) against S. typhimurium a gram-negative and BEA at the origin against S. 
pyogenes. In some cases no inhibition of microbial growth was observed on some parts of the 
plate; these findings agree with previously published results of Masoko and Eloff (2005). The 
absence of activity was interpreted to be the evaporation of active compounds or presence of 
very little amount of active compounds during the removal of eluents (Masoko and Eloff, 
2008). It might also be due to the traces of some solvents left in the chromatograms. Another 
explanation for the observed non-activity could be due to very weak activity of the extracts 
against the selected microorganisms. The active spots appeared as white/yellow spots on a 
purple/pink background. 
The solvent system that exhibited the best separation of compounds (CEF) was chosen for 
column chromatography.  CEF separated 12 compounds at 100 mg/mL concentration more 
than EMW and CEF solvent combinations (Table 3). Initially 22 fractions of 200 mL (Njume 
et al., 2011)  were collected in separated bottles and coded C and CEF for fractions collected 
from chloroform and solvent system Chloroform/ Ethyl Acetate/ Formic acid, respectively.  
The first few fractions collected in CEF exhibited a light brown colour but TLC profile 
indicated different compounds and therefore were not combined. TLC analysis of fractions 
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was therefore compulsory even for fractions which indicated the same colour. Most fractions 
collected in this study were colourless. TLC fractions of 4-6, 8-10 and 14-16 indicated similar 
compounds, and were combined to yield 16 compounds (Table 5).  
Eluted compounds fractions were assayed for MIC90 using 96-well microdilution method.  
MIC ranged between 0.0006 - 2.5 mg/mL and that of ciprofloxacin ranged between 0.0012 - 
0.0781mg/mL (Table 6). The lowest MIC (0.0012 mg/mL) of CEF 18 (F18) against S. 
pyogenes compared favourably to that of ciprofloxacin (P < 0.05). This result may indicate 
that CEF 18 (F18) has the same inhibitory potential with ciprofloxacin (positive control). 
Most high MIC values of 2.5 mg/mL were observed against gram-negative bacteria (S. 
typhimurium and P. shigelloides); this may be related to the thicker cell wall composition of 
gram - negatives. The results indicate that most fractions demonstrated a good inhibition 
against the organisms. All fractions collected from CEF demonstrated a good inhibition 
against S. aureus. Poor activity of some fractions may be due to insufficient amount of active 
ingredients.  
Three fractions CEF 3 (F3), CEF 11 (F11), and CEF 12 (F12) were analysed by GC - MS to 
determine the type(s) of compounds present. These fractions were selected based on their 
purity [less compounds shown by TLC profile (≤ 2 bands)] and their activity on the 
organisms. CEF 3 (F3) and CEF 11 (F11) showed one band on the TLC plate indicating a 
better purity of the compounds while CEF 12 showed two bands. Although CEF 7, CEF 14-
16, CEF 17 and CEF 18 indicated two compounds on the TLC plate, they did not show 
inhibitory activity against all the four tested organisms therefore were not analyzed by GC-
MS.  CEF 17 was not effective against P. shigelloides and CEF (14 -16, 17, 18) were found 
ineffective against S. typhimurium. CEF 3 (F3) showed an Rf  value of 0.153, CEF 11 (F11) 
0.13 and CEF 12 (F12) (0.15 and 0.18). The chemical compounds identified by GC-MS are 
presented in Table 6. CEF 3 (F3) showed high level of Linoleic acid (26.60 %), followed by 
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Hexadecanoic acid (25.07 %) and 9-Octadecenoic acid (24.81 %), and only 10 peaks were 
identified which indicate the presence of 10 compounds. CEF 11 (F11) had 1, 2-
Benzenedicarboxylic acid [Di-(2-ethylhexyl) phthalate] (100 %) and only one peak was 
identified from this fraction.  CEF12 (F12) showed major compounds of 2, 3-Dihydro-3, 5-
dihydroxy-6-methyl (24.16 %), followed by 1-Butanol (15.72 %) and 9-Octadecenamide 
(13.82 %) and 14 peaks were identified on the GC-MS chromatogram. Linoleic acid is an 
unsaturated fatty acid and a carboxylic acid that belong to an essential fatty acid. 
Hexadecanoic acid is also known as palmitic acid, a common saturated fatty acid usually 
found in plants and animals. Octadecanoic acid (stearic acid) is a saturated fatty acid, one of 
the common long-chain fatty acid. 1, 2-Benzenedicarboxylic acid (phthalic acid) and 1-
butanol (primary alcohol) and 9-Octadecenamide (Amide) were also dominant chemical 
compounds found. Among other chemical compounds detected by GC-MS were 3, 4, 8-
Trimethyl - 2 - nonenal (2.07 %), Hexadecanamide (1.59 %), n-Tetradecanoic acid amide 
(2.55 %), though small quantities of these compounds were observed (Table 6). The 
compound 3, 4, 8 - Trimethyl - 2 - nonenal could probably be new since no report exist on it 
in literature.  
Most compounds revealed by GC-MS in this study were fatty acids and they have been 
reported to have antibacterial and antifungal activity (McGraw et al., 2002; Seidel and Tailor, 
2004; Russell, 1991). The presence of these chemical compounds correlate the findings of 
several authors (McGraw et al., 2002; Siedel and Taylor, 2004; Eleyinmi et al., 2006; 
Gopalakrishan et al., 2011) who using GC-MS analysis revealed the presence of 
hexadecanoic, benzenedicarboxylic, polyunsaturated fatty acid (Linoleic), octadecanoic, 
methyl ester Tetradecanoic (revealed by GC-MS in CEF 12),  saturated fatty acids (stearic 
and palmitic). There are few reports on the identification of compounds in Garcinia kola 
seeds by GC-MS analysis. The observed wide range of antimicrobial properties of methanolic 
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extract and fractions can be explained by the presence of 1, 2-Benzenedicarboxylic acid (100 
%), Linoleic acid (26.60 %), Hexadecanoic acid, palmitic (25.07 %), 2, 3-Dihydro-3, 5-
dihydroxy-6-methyl (24.16 %), and 9-Octadecadienoic acid (24.81 %). These chemical 
compounds which are volatiles are the major constituents and occupied large area 
percentages.  
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5.2 Conclusion 
From the results of this study, the following conclusions can be drawn. 
1.  All the extracts of G. kola seeds with the exception of the water extract showed varying  
    degrees of antimicrobial activity on the microorganisms tested, with methanol extract   
    demonstrating the best activity (bigger zones) against all the organims at all  
    concentrations. 
2. The methanol extract inhibited the growth of all organisms, with MIC ranging between  
    0.0012 - 0.0195 mg/mL and that of fractions from 0.0006 - 2.5 mg/mL against all tested  
    organisms. 
3. The MBC of the methanol extract ranged from 0.081 - 2.5 mg/mL. 
4. The major chemical compounds revealed by GC-MS analysis were 1, 2-  
   Benzenedicarboxylic acid (100 %), Linoleic acid (26.60 %), Hexadecanoic acid, palmitic  
   (25.07 %), 2, 3-Dihydro-3, 5-dihydroxy-6-methyl (24.16 %) and 9-Octadecadienoic acid  
   (24.81 %) which are believed to be responsible for antimicrobial activity. 
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5.3 Recommendations 
Based on the results of this study, the following recommendations are suggested: 
1. Further analysis should be done to identify the non-volatile compounds by High      
    Performance Liquid Chromatography (HPLC) and Nuclear Magnetic Resonance (NMR). 
2. The antioxidant activity of Garcinia kola seeds since the plant has been reported to have  
    diverse bioactivity.  
3. It is also important to evaluate the toxicity of the plant crude extracts in order to   
    determine its safety parameters. 
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APPENDIX: STATISTICAL ANALYSIS 
Table 1: Multiple comparisons of zone diameters of seeds extracts of G.kola and 
ciprofloxacin. 
1, ethyl acetate extract; 2, acetone; 3, ethanol; 4, methanol; 5, water; 6,6 
ciprofloxacin 
Zone diameter 
Tukey HSD 
 
(I) Exts (J) Exts 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
1 2 -2.833 2.444 .854 -10.01 4.34 
3 -6.750 2.444 .077 -13.92 .42 
4 -10.250
*
 2.444 .001 -17.42 -3.08 
5 9.333
*
 2.444 .004 2.16 16.51 
6 -18.917
*
 2.444 .000 -26.09 -11.74 
2 1 2.833 2.444 .854 -4.34 10.01 
3 -3.917 2.444 .600 -11.09 3.26 
4 -7.417
*
 2.444 .039 -14.59 -.24 
5 12.167
*
 2.444 .000 4.99 19.34 
6 -16.083
*
 2.444 .000 -23.26 -8.91 
3 1 6.750 2.444 .077 -.42 13.92 
2 3.917 2.444 .600 -3.26 11.09 
4 -3.500 2.444 .707 -10.67 3.67 
5 16.083
*
 2.444 .000 8.91 23.26 
6 -12.167
*
 2.444 .000 -19.34 -4.99 
4 1 10.250
*
 2.444 .001 3.08 17.42 
2 7.417
*
 2.444 .039 .24 14.59 
3 3.500 2.444 .707 -3.67 10.67 
5 19.583
*
 2.444 .000 12.41 26.76 
6 -8.667
*
 2.444 .009 -15.84 -1.49 
5 1 -9.333
*
 2.444 .004 -16.51 -2.16 
2 -12.167
*
 2.444 .000 -19.34 -4.99 
3 -16.083
*
 2.444 .000 -23.26 -8.91 
4 -19.583
*
 2.444 .000 -26.76 -12.41 
6 -28.250
*
 2.444 .000 -35.42 -21.08 
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6 1 18.917
*
 2.444 .000 11.74 26.09 
2 16.083
*
 2.444 .000 8.91 23.26 
3 12.167
*
 2.444 .000 4.99 19.34 
4 8.667
*
 2.444 .009 1.49 15.84 
5 28.250
*
 2.444 .000 21.08 35.42 
*. The mean difference is significant at the 0.05 level. 
 
 
 
 
 
 
 Table 2: Multiple Comparisons of MIC values of methanol and ciprofloxacin 
4, methanol extract; 6, ciprofloxacin 
MIC 
Tukey HSD 
(I) Exts (J) Exts 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
0 4 -.4900000 .2359868 .150 -1.148876 .168876 
6 -.0070000 .2359868 1.000 -.665876 .651876 
4 0 .4900000 .2359868 .150 -.168876 1.148876 
6 .4830000 .2359868 .157 -.175876 1.141876 
6 0 .0070000 .2359868 1.000 -.651876 .665876 
4 -.4830000 .2359868 .157 -1.141876 .175876 
*. The mean difference is significant at the 0.05 level. 
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Table 3: Multiple Comparisons of MBC values of methanol and ciprofloxacin 
4, methanol extract; 6, ciprofloxacin 
MBC 
Tukey HSD 
(I) Exts (J) Exts 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
0 4 -1.0202500 .4562476 .118 -2.294096 .253596 
6 -.1758000 .4562476 .922 -1.449646 1.098046 
4 0 1.0202500 .4562476 .118 -.253596 2.294096 
6 .8444500 .4562476 .208 -.429396 2.118296 
6 0 .1758000 .4562476 .922 -1.098046 1.449646 
4 -.8444500 .4562476 .208 -2.118296 .429396 
*. The mean difference is significant at the 0.05 level. 
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Table 4:  Mulitiple comparisons of MIC values of fractions of G.kola seeds and 
ciprofloxacin. 
1 C1, 2 C2, 3 C3, 4C4, 5 CEF1, 6 CEF 2, 7 CEF 3, 8 CEF 4-6, 9 CEF 7, 10 CEF 8-10, 11 CEF 11, 12 
CEF 12, 13 CEF 13,  14 CEF 14-16,  15 CEF 17, 16 CEF 18, 17 Ciprofolxacin.   
Turkey HSD 
(I) fracn (J) fracn 
Mean 
Difference (I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
1 2 .00000000 .69992933 1.000 -2.5464677 2.5464677 
3 1.24317250 .69992933 .928 -1.3032952 3.7896402 
4 1.24733500 .69992933 .926 -1.2991327 3.7938027 
5 2.25092500 .69992933 .140 -.2955427 4.7973927 
6 2.10337500 .69992933 .220 -.4430927 4.6498427 
7 2.38280000 .69992933 .090 -.1636677 4.9292677 
8 .61900000 .69992933 1.000 -1.9274677 3.1654677 
9 1.67845000 .69992933 .586 -.8680177 4.2249177 
10 1.23912500 .69992933 .929 -1.3073427 3.7855927 
11 1.23175000 .69992933 .933 -1.3147177 3.7782177 
12 1.98472500 .69992933 .303 -.5617427 4.5311927 
13 1.54425000 .69992933 .716 -1.0022177 4.0907177 
14 1.07812500 .69992933 .978 -1.4683427 3.6245927 
15 1.77550000 .69992933 .490 -.7709677 4.3219677 
16 1.83075000 .69992933 .437 -.7157177 4.3772177 
17 2.47865000 .69992933 .064 -.0678177 5.0251177 
2 1 .00000000 .69992933 1.000 -2.5464677 2.5464677 
3 1.24317250 .69992933 .928 -1.3032952 3.7896402 
4 1.24733500 .69992933 .926 -1.2991327 3.7938027 
5 2.25092500 .69992933 .140 -.2955427 4.7973927 
6 2.10337500 .69992933 .220 -.4430927 4.6498427 
7 2.38280000 .69992933 .090 -.1636677 4.9292677 
8 .61900000 .69992933 1.000 -1.9274677 3.1654677 
9 1.67845000 .69992933 .586 -.8680177 4.2249177 
10 1.23912500 .69992933 .929 -1.3073427 3.7855927 
11 1.23175000 .69992933 .933 -1.3147177 3.7782177 
12 1.98472500 .69992933 .303 -.5617427 4.5311927 
13 1.54425000 .69992933 .716 -1.0022177 4.0907177 
14 1.07812500 .69992933 .978 -1.4683427 3.6245927 
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15 1.77550000 .69992933 .490 -.7709677 4.3219677 
16 1.83075000 .69992933 .437 -.7157177 4.3772177 
17 2.47865000 .69992933 .064 -.0678177 5.0251177 
3 1 -1.24317250 .69992933 .928 -3.7896402 1.3032952 
2 -1.24317250 .69992933 .928 -3.7896402 1.3032952 
4 .00416250 .69992933 1.000 -2.5423052 2.5506302 
5 1.00775250 .69992933 .988 -1.5387152 3.5542202 
6 .86020250 .69992933 .998 -1.6862652 3.4066702 
7 1.13962750 .69992933 .964 -1.4068402 3.6860952 
8 -.62417250 .69992933 1.000 -3.1706402 1.9222952 
9 .43527750 .69992933 1.000 -2.1111902 2.9817452 
10 -.00404750 .69992933 1.000 -2.5505152 2.5424202 
11 -.01142250 .69992933 1.000 -2.5578902 2.5350452 
12 .74155250 .69992933 1.000 -1.8049152 3.2880202 
13 .30107750 .69992933 1.000 -2.2453902 2.8475452 
14 -.16504750 .69992933 1.000 -2.7115152 2.3814202 
15 .53232750 .69992933 1.000 -2.0141402 3.0787952 
16 .58757750 .69992933 1.000 -1.9588902 3.1340452 
17 1.23547750 .69992933 .931 -1.3109902 3.7819452 
4 1 -1.24733500 .69992933 .926 -3.7938027 1.2991327 
2 -1.24733500 .69992933 .926 -3.7938027 1.2991327 
3 -.00416250 .69992933 1.000 -2.5506302 2.5423052 
5 1.00359000 .69992933 .989 -1.5428777 3.5500577 
6 .85604000 .69992933 .998 -1.6904277 3.4025077 
7 1.13546500 .69992933 .965 -1.4110027 3.6819327 
8 -.62833500 .69992933 1.000 -3.1748027 1.9181327 
9 .43111500 .69992933 1.000 -2.1153527 2.9775827 
10 -.00821000 .69992933 1.000 -2.5546777 2.5382577 
11 -.01558500 .69992933 1.000 -2.5620527 2.5308827 
12 .73739000 .69992933 1.000 -1.8090777 3.2838577 
13 .29691500 .69992933 1.000 -2.2495527 2.8433827 
14 -.16921000 .69992933 1.000 -2.7156777 2.3772577 
15 .52816500 .69992933 1.000 -2.0183027 3.0746327 
16 .58341500 .69992933 1.000 -1.9630527 3.1298827 
17 1.23131500 .69992933 .933 -1.3151527 3.7777827 
5 1 -2.25092500 .69992933 .140 -4.7973927 .2955427 
2 -2.25092500 .69992933 .140 -4.7973927 .2955427 
3 -1.00775250 .69992933 .988 -3.5542202 1.5387152 
4 -1.00359000 .69992933 .989 -3.5500577 1.5428777 
6 -.14755000 .69992933 1.000 -2.6940177 2.3989177 
7 .13187500 .69992933 1.000 -2.4145927 2.6783427 
8 -1.63192500 .69992933 .632 -4.1783927 .9145427 
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9 -.57247500 .69992933 1.000 -3.1189427 1.9739927 
10 -1.01180000 .69992933 .988 -3.5582677 1.5346677 
11 -1.01917500 .69992933 .987 -3.5656427 1.5272927 
12 -.26620000 .69992933 1.000 -2.8126677 2.2802677 
13 -.70667500 .69992933 1.000 -3.2531427 1.8397927 
14 -1.17280000 .69992933 .954 -3.7192677 1.3736677 
15 -.47542500 .69992933 1.000 -3.0218927 2.0710427 
16 -.42017500 .69992933 1.000 -2.9666427 2.1262927 
17 .22772500 .69992933 1.000 -2.3187427 2.7741927 
6 1 -2.10337500 .69992933 .220 -4.6498427 .4430927 
2 -2.10337500 .69992933 .220 -4.6498427 .4430927 
3 -.86020250 .69992933 .998 -3.4066702 1.6862652 
4 -.85604000 .69992933 .998 -3.4025077 1.6904277 
5 .14755000 .69992933 1.000 -2.3989177 2.6940177 
7 .27942500 .69992933 1.000 -2.2670427 2.8258927 
8 -1.48437500 .69992933 .769 -4.0308427 1.0620927 
9 -.42492500 .69992933 1.000 -2.9713927 2.1215427 
10 -.86425000 .69992933 .998 -3.4107177 1.6822177 
11 -.87162500 .69992933 .997 -3.4180927 1.6748427 
12 -.11865000 .69992933 1.000 -2.6651177 2.4278177 
13 -.55912500 .69992933 1.000 -3.1055927 1.9873427 
14 -1.02525000 .69992933 .986 -3.5717177 1.5212177 
15 -.32787500 .69992933 1.000 -2.8743427 2.2185927 
16 -.27262500 .69992933 1.000 -2.8190927 2.2738427 
17 .37527500 .69992933 1.000 -2.1711927 2.9217427 
7 1 -2.38280000 .69992933 .090 -4.9292677 .1636677 
2 -2.38280000 .69992933 .090 -4.9292677 .1636677 
3 -1.13962750 .69992933 .964 -3.6860952 1.4068402 
4 -1.13546500 .69992933 .965 -3.6819327 1.4110027 
5 -.13187500 .69992933 1.000 -2.6783427 2.4145927 
6 -.27942500 .69992933 1.000 -2.8258927 2.2670427 
8 -1.76380000 .69992933 .501 -4.3102677 .7826677 
9 -.70435000 .69992933 1.000 -3.2508177 1.8421177 
10 -1.14367500 .69992933 .963 -3.6901427 1.4027927 
11 -1.15105000 .69992933 .961 -3.6975177 1.3954177 
12 -.39807500 .69992933 1.000 -2.9445427 2.1483927 
13 -.83855000 .69992933 .998 -3.3850177 1.7079177 
14 -1.30467500 .69992933 .897 -3.8511427 1.2417927 
15 -.60730000 .69992933 1.000 -3.1537677 1.9391677 
16 -.55205000 .69992933 1.000 -3.0985177 1.9944177 
17 .09585000 .69992933 1.000 -2.4506177 2.6423177 
8 1 -.61900000 .69992933 1.000 -3.1654677 1.9274677 
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2 -.61900000 .69992933 1.000 -3.1654677 1.9274677 
3 .62417250 .69992933 1.000 -1.9222952 3.1706402 
4 .62833500 .69992933 1.000 -1.9181327 3.1748027 
5 1.63192500 .69992933 .632 -.9145427 4.1783927 
6 1.48437500 .69992933 .769 -1.0620927 4.0308427 
7 1.76380000 .69992933 .501 -.7826677 4.3102677 
9 1.05945000 .69992933 .981 -1.4870177 3.6059177 
10 .62012500 .69992933 1.000 -1.9263427 3.1665927 
11 .61275000 .69992933 1.000 -1.9337177 3.1592177 
12 1.36572500 .69992933 .860 -1.1807427 3.9121927 
13 .92525000 .69992933 .995 -1.6212177 3.4717177 
14 .45912500 .69992933 1.000 -2.0873427 3.0055927 
15 1.15650000 .69992933 .959 -1.3899677 3.7029677 
16 1.21175000 .69992933 .941 -1.3347177 3.7582177 
17 1.85965000 .69992933 .410 -.6868177 4.4061177 
9 1 -1.67845000 .69992933 .586 -4.2249177 .8680177 
2 -1.67845000 .69992933 .586 -4.2249177 .8680177 
3 -.43527750 .69992933 1.000 -2.9817452 2.1111902 
4 -.43111500 .69992933 1.000 -2.9775827 2.1153527 
5 .57247500 .69992933 1.000 -1.9739927 3.1189427 
6 .42492500 .69992933 1.000 -2.1215427 2.9713927 
7 .70435000 .69992933 1.000 -1.8421177 3.2508177 
8 -1.05945000 .69992933 .981 -3.6059177 1.4870177 
10 -.43932500 .69992933 1.000 -2.9857927 2.1071427 
11 -.44670000 .69992933 1.000 -2.9931677 2.0997677 
12 .30627500 .69992933 1.000 -2.2401927 2.8527427 
13 -.13420000 .69992933 1.000 -2.6806677 2.4122677 
14 -.60032500 .69992933 1.000 -3.1467927 1.9461427 
15 .09705000 .69992933 1.000 -2.4494177 2.6435177 
16 .15230000 .69992933 1.000 -2.3941677 2.6987677 
17 .80020000 .69992933 .999 -1.7462677 3.3466677 
10 1 -1.23912500 .69992933 .929 -3.7855927 1.3073427 
2 -1.23912500 .69992933 .929 -3.7855927 1.3073427 
3 .00404750 .69992933 1.000 -2.5424202 2.5505152 
4 .00821000 .69992933 1.000 -2.5382577 2.5546777 
5 1.01180000 .69992933 .988 -1.5346677 3.5582677 
6 .86425000 .69992933 .998 -1.6822177 3.4107177 
7 1.14367500 .69992933 .963 -1.4027927 3.6901427 
8 -.62012500 .69992933 1.000 -3.1665927 1.9263427 
9 .43932500 .69992933 1.000 -2.1071427 2.9857927 
11 -.00737500 .69992933 1.000 -2.5538427 2.5390927 
12 .74560000 .69992933 1.000 -1.8008677 3.2920677 
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13 .30512500 .69992933 1.000 -2.2413427 2.8515927 
14 -.16100000 .69992933 1.000 -2.7074677 2.3854677 
15 .53637500 .69992933 1.000 -2.0100927 3.0828427 
16 .59162500 .69992933 1.000 -1.9548427 3.1380927 
17 1.23952500 .69992933 .929 -1.3069427 3.7859927 
11 1 -1.23175000 .69992933 .933 -3.7782177 1.3147177 
2 -1.23175000 .69992933 .933 -3.7782177 1.3147177 
3 .01142250 .69992933 1.000 -2.5350452 2.5578902 
4 .01558500 .69992933 1.000 -2.5308827 2.5620527 
5 1.01917500 .69992933 .987 -1.5272927 3.5656427 
6 .87162500 .69992933 .997 -1.6748427 3.4180927 
7 1.15105000 .69992933 .961 -1.3954177 3.6975177 
8 -.61275000 .69992933 1.000 -3.1592177 1.9337177 
9 .44670000 .69992933 1.000 -2.0997677 2.9931677 
10 .00737500 .69992933 1.000 -2.5390927 2.5538427 
12 .75297500 .69992933 1.000 -1.7934927 3.2994427 
13 .31250000 .69992933 1.000 -2.2339677 2.8589677 
14 -.15362500 .69992933 1.000 -2.7000927 2.3928427 
15 .54375000 .69992933 1.000 -2.0027177 3.0902177 
16 .59900000 .69992933 1.000 -1.9474677 3.1454677 
17 1.24690000 .69992933 .926 -1.2995677 3.7933677 
12 1 -1.98472500 .69992933 .303 -4.5311927 .5617427 
2 -1.98472500 .69992933 .303 -4.5311927 .5617427 
3 -.74155250 .69992933 1.000 -3.2880202 1.8049152 
4 -.73739000 .69992933 1.000 -3.2838577 1.8090777 
5 .26620000 .69992933 1.000 -2.2802677 2.8126677 
6 .11865000 .69992933 1.000 -2.4278177 2.6651177 
7 .39807500 .69992933 1.000 -2.1483927 2.9445427 
8 -1.36572500 .69992933 .860 -3.9121927 1.1807427 
9 -.30627500 .69992933 1.000 -2.8527427 2.2401927 
10 -.74560000 .69992933 1.000 -3.2920677 1.8008677 
11 -.75297500 .69992933 1.000 -3.2994427 1.7934927 
13 -.44047500 .69992933 1.000 -2.9869427 2.1059927 
14 -.90660000 .69992933 .996 -3.4530677 1.6398677 
15 -.20922500 .69992933 1.000 -2.7556927 2.3372427 
16 -.15397500 .69992933 1.000 -2.7004427 2.3924927 
17 .49392500 .69992933 1.000 -2.0525427 3.0403927 
13 1 -1.54425000 .69992933 .716 -4.0907177 1.0022177 
2 -1.54425000 .69992933 .716 -4.0907177 1.0022177 
3 -.30107750 .69992933 1.000 -2.8475452 2.2453902 
4 -.29691500 .69992933 1.000 -2.8433827 2.2495527 
5 .70667500 .69992933 1.000 -1.8397927 3.2531427 
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6 .55912500 .69992933 1.000 -1.9873427 3.1055927 
7 .83855000 .69992933 .998 -1.7079177 3.3850177 
8 -.92525000 .69992933 .995 -3.4717177 1.6212177 
9 .13420000 .69992933 1.000 -2.4122677 2.6806677 
10 -.30512500 .69992933 1.000 -2.8515927 2.2413427 
11 -.31250000 .69992933 1.000 -2.8589677 2.2339677 
12 .44047500 .69992933 1.000 -2.1059927 2.9869427 
14 -.46612500 .69992933 1.000 -3.0125927 2.0803427 
15 .23125000 .69992933 1.000 -2.3152177 2.7777177 
16 .28650000 .69992933 1.000 -2.2599677 2.8329677 
17 .93440000 .69992933 .995 -1.6120677 3.4808677 
14 1 -1.07812500 .69992933 .978 -3.6245927 1.4683427 
2 -1.07812500 .69992933 .978 -3.6245927 1.4683427 
3 .16504750 .69992933 1.000 -2.3814202 2.7115152 
4 .16921000 .69992933 1.000 -2.3772577 2.7156777 
5 1.17280000 .69992933 .954 -1.3736677 3.7192677 
6 1.02525000 .69992933 .986 -1.5212177 3.5717177 
7 1.30467500 .69992933 .897 -1.2417927 3.8511427 
8 -.45912500 .69992933 1.000 -3.0055927 2.0873427 
9 .60032500 .69992933 1.000 -1.9461427 3.1467927 
10 .16100000 .69992933 1.000 -2.3854677 2.7074677 
11 .15362500 .69992933 1.000 -2.3928427 2.7000927 
12 .90660000 .69992933 .996 -1.6398677 3.4530677 
13 .46612500 .69992933 1.000 -2.0803427 3.0125927 
15 .69737500 .69992933 1.000 -1.8490927 3.2438427 
16 .75262500 .69992933 1.000 -1.7938427 3.2990927 
17 1.40052500 .69992933 .836 -1.1459427 3.9469927 
15 1 -1.77550000 .69992933 .490 -4.3219677 .7709677 
2 -1.77550000 .69992933 .490 -4.3219677 .7709677 
3 -.53232750 .69992933 1.000 -3.0787952 2.0141402 
4 -.52816500 .69992933 1.000 -3.0746327 2.0183027 
5 .47542500 .69992933 1.000 -2.0710427 3.0218927 
6 .32787500 .69992933 1.000 -2.2185927 2.8743427 
7 .60730000 .69992933 1.000 -1.9391677 3.1537677 
8 -1.15650000 .69992933 .959 -3.7029677 1.3899677 
9 -.09705000 .69992933 1.000 -2.6435177 2.4494177 
10 -.53637500 .69992933 1.000 -3.0828427 2.0100927 
11 -.54375000 .69992933 1.000 -3.0902177 2.0027177 
12 .20922500 .69992933 1.000 -2.3372427 2.7556927 
13 -.23125000 .69992933 1.000 -2.7777177 2.3152177 
14 -.69737500 .69992933 1.000 -3.2438427 1.8490927 
16 .05525000 .69992933 1.000 -2.4912177 2.6017177 
96 
 
17 .70315000 .69992933 1.000 -1.8433177 3.2496177 
16 1 -1.83075000 .69992933 .437 -4.3772177 .7157177 
2 -1.83075000 .69992933 .437 -4.3772177 .7157177 
3 -.58757750 .69992933 1.000 -3.1340452 1.9588902 
4 -.58341500 .69992933 1.000 -3.1298827 1.9630527 
5 .42017500 .69992933 1.000 -2.1262927 2.9666427 
6 .27262500 .69992933 1.000 -2.2738427 2.8190927 
7 .55205000 .69992933 1.000 -1.9944177 3.0985177 
8 -1.21175000 .69992933 .941 -3.7582177 1.3347177 
9 -.15230000 .69992933 1.000 -2.6987677 2.3941677 
10 -.59162500 .69992933 1.000 -3.1380927 1.9548427 
11 -.59900000 .69992933 1.000 -3.1454677 1.9474677 
12 .15397500 .69992933 1.000 -2.3924927 2.7004427 
13 -.28650000 .69992933 1.000 -2.8329677 2.2599677 
14 -.75262500 .69992933 1.000 -3.2990927 1.7938427 
15 -.05525000 .69992933 1.000 -2.6017177 2.4912177 
17 .64790000 .69992933 1.000 -1.8985677 3.1943677 
17 1 -2.47865000 .69992933 .064 -5.0251177 .0678177 
2 -2.47865000 .69992933 .064 -5.0251177 .0678177 
3 -1.23547750 .69992933 .931 -3.7819452 1.3109902 
4 -1.23131500 .69992933 .933 -3.7777827 1.3151527 
5 -.22772500 .69992933 1.000 -2.7741927 2.3187427 
6 -.37527500 .69992933 1.000 -2.9217427 2.1711927 
7 -.09585000 .69992933 1.000 -2.6423177 2.4506177 
8 -1.85965000 .69992933 .410 -4.4061177 .6868177 
9 -.80020000 .69992933 .999 -3.3466677 1.7462677 
10 -1.23952500 .69992933 .929 -3.7859927 1.3069427 
11 -1.24690000 .69992933 .926 -3.7933677 1.2995677 
12 -.49392500 .69992933 1.000 -3.0403927 2.0525427 
13 -.93440000 .69992933 .995 -3.4808677 1.6120677 
14 -1.40052500 .69992933 .836 -3.9469927 1.1459427 
15 -.70315000 .69992933 1.000 -3.2496177 1.8433177 
16 -.64790000 .69992933 1.000 -3.1943677 1.8985677 
 
 
 
 
